TW201300361A - 抑制香草類化物受體(vanilloid receptor)次型1(vr1)受體之稠合化合物 - Google Patents
抑制香草類化物受體(vanilloid receptor)次型1(vr1)受體之稠合化合物 Download PDFInfo
- Publication number
- TW201300361A TW201300361A TW101107398A TW101107398A TW201300361A TW 201300361 A TW201300361 A TW 201300361A TW 101107398 A TW101107398 A TW 101107398A TW 101107398 A TW101107398 A TW 101107398A TW 201300361 A TW201300361 A TW 201300361A
- Authority
- TW
- Taiwan
- Prior art keywords
- compound
- formula
- dihydro
- indol
- urea
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 660
- 108010025083 TRPV1 receptor Proteins 0.000 title claims abstract description 22
- 102000005962 receptors Human genes 0.000 title claims description 12
- 102100029613 Transient receptor potential cation channel subfamily V member 1 Human genes 0.000 title claims description 9
- 238000000034 method Methods 0.000 claims abstract description 142
- 150000003839 salts Chemical class 0.000 claims abstract description 54
- 239000000651 prodrug Substances 0.000 claims abstract description 30
- 229940002612 prodrug Drugs 0.000 claims abstract description 30
- 208000002193 Pain Diseases 0.000 claims abstract description 15
- 230000036407 pain Effects 0.000 claims abstract description 15
- 230000008569 process Effects 0.000 claims abstract description 13
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 363
- -1 decylalkyl Chemical group 0.000 claims description 210
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 198
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 161
- 125000000217 alkyl group Chemical group 0.000 claims description 126
- 239000000203 mixture Substances 0.000 claims description 114
- 239000001257 hydrogen Substances 0.000 claims description 109
- 229910052739 hydrogen Inorganic materials 0.000 claims description 109
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 106
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 90
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 83
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 81
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 70
- 239000002904 solvent Substances 0.000 claims description 70
- 239000004202 carbamide Substances 0.000 claims description 69
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 66
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 54
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 53
- 238000002360 preparation method Methods 0.000 claims description 49
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 48
- 229910052757 nitrogen Inorganic materials 0.000 claims description 46
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 41
- 150000002431 hydrogen Chemical class 0.000 claims description 40
- 229910052736 halogen Inorganic materials 0.000 claims description 39
- 150000002367 halogens Chemical class 0.000 claims description 39
- 239000002253 acid Substances 0.000 claims description 35
- 125000003545 alkoxy group Chemical group 0.000 claims description 33
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims description 31
- 125000003118 aryl group Chemical group 0.000 claims description 31
- 125000001188 haloalkyl group Chemical group 0.000 claims description 31
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 31
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 28
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 28
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 26
- 125000004966 cyanoalkyl group Chemical group 0.000 claims description 26
- 125000004438 haloalkoxy group Chemical group 0.000 claims description 26
- 238000011282 treatment Methods 0.000 claims description 24
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 22
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 22
- 125000000623 heterocyclic group Chemical group 0.000 claims description 19
- 201000010099 disease Diseases 0.000 claims description 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 18
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 18
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 claims description 18
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 claims description 16
- 125000005243 carbonyl alkyl group Chemical group 0.000 claims description 16
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 16
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 16
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 16
- 125000005078 alkoxycarbonylalkyl group Chemical group 0.000 claims description 15
- 125000004414 alkyl thio group Chemical group 0.000 claims description 15
- 125000000304 alkynyl group Chemical group 0.000 claims description 15
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 15
- 125000003342 alkenyl group Chemical group 0.000 claims description 14
- 125000005093 alkyl carbonyl alkyl group Chemical group 0.000 claims description 14
- 125000005083 alkoxyalkoxy group Chemical group 0.000 claims description 13
- 125000004181 carboxyalkyl group Chemical group 0.000 claims description 13
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 13
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 13
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 12
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims description 11
- 125000004995 haloalkylthio group Chemical group 0.000 claims description 11
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 11
- 238000000746 purification Methods 0.000 claims description 11
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 claims description 10
- 229910052799 carbon Inorganic materials 0.000 claims description 9
- 235000010288 sodium nitrite Nutrition 0.000 claims description 9
- INUNLMUAPJVRME-UHFFFAOYSA-N 3-chloropropanoyl chloride Chemical compound ClCCC(Cl)=O INUNLMUAPJVRME-UHFFFAOYSA-N 0.000 claims description 8
- OCKPCBLVNKHBMX-UHFFFAOYSA-N butylbenzene Chemical compound CCCCC1=CC=CC=C1 OCKPCBLVNKHBMX-UHFFFAOYSA-N 0.000 claims description 8
- 125000005358 mercaptoalkyl group Chemical group 0.000 claims description 8
- DRRCSCZWHQJCDS-UHFFFAOYSA-N CC(C)(C)C1=CC2=C(C=C1)N(CC2)NC(=O)NC3=CC=CC4=C3C=CN=C4 Chemical compound CC(C)(C)C1=CC2=C(C=C1)N(CC2)NC(=O)NC3=CC=CC4=C3C=CN=C4 DRRCSCZWHQJCDS-UHFFFAOYSA-N 0.000 claims description 7
- BOBJECZWRXTBRH-UHFFFAOYSA-N CC1=CC2=C(C=CC=C2NC(=O)NN3CCC4=C3C=CC(=C4)C(C)(C)C)C=N1 Chemical compound CC1=CC2=C(C=CC=C2NC(=O)NN3CCC4=C3C=CC(=C4)C(C)(C)C)C=N1 BOBJECZWRXTBRH-UHFFFAOYSA-N 0.000 claims description 7
- 208000004454 Hyperalgesia Diseases 0.000 claims description 7
- 239000012279 sodium borohydride Substances 0.000 claims description 7
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 7
- 125000001072 heteroaryl group Chemical group 0.000 claims description 6
- HFCFJYRLBAANKN-UHFFFAOYSA-N 2-methyl-3-nitroaniline Chemical compound CC1=C(N)C=CC=C1[N+]([O-])=O HFCFJYRLBAANKN-UHFFFAOYSA-N 0.000 claims description 5
- XJCVRTZCHMZPBD-UHFFFAOYSA-N 3-nitroaniline Chemical class NC1=CC=CC([N+]([O-])=O)=C1 XJCVRTZCHMZPBD-UHFFFAOYSA-N 0.000 claims description 5
- WCNAYRYRQAXMEY-UHFFFAOYSA-N COC1=C2CCN(C2=CC=C1OC)NC(=O)NC1=C2C=NNC2=CC=C1 Chemical compound COC1=C2CCN(C2=CC=C1OC)NC(=O)NC1=C2C=NNC2=CC=C1 WCNAYRYRQAXMEY-UHFFFAOYSA-N 0.000 claims description 5
- 206010020853 Hypertonic bladder Diseases 0.000 claims description 5
- 208000009722 Overactive Urinary Bladder Diseases 0.000 claims description 5
- 206010046543 Urinary incontinence Diseases 0.000 claims description 5
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims description 5
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 claims description 5
- 125000002757 morpholinyl group Chemical group 0.000 claims description 5
- 208000020629 overactive bladder Diseases 0.000 claims description 5
- 229910052760 oxygen Inorganic materials 0.000 claims description 5
- 125000003386 piperidinyl group Chemical group 0.000 claims description 5
- 125000004076 pyridyl group Chemical group 0.000 claims description 5
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims description 5
- 208000035154 Hyperesthesia Diseases 0.000 claims description 4
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 claims description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 4
- 229910052717 sulfur Inorganic materials 0.000 claims description 4
- 235000012141 vanillin Nutrition 0.000 claims description 4
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 claims description 4
- VTVZETXZBPJECM-UHFFFAOYSA-N 1-[4-(3,3-difluoropiperidin-1-yl)-2,3-dihydro-1h-inden-1-yl]-3-(1h-indazol-4-yl)urea Chemical compound C1C(F)(F)CCCN1C1=CC=CC2=C1CCC2NC(=O)NC1=CC=CC2=C1C=NN2 VTVZETXZBPJECM-UHFFFAOYSA-N 0.000 claims description 3
- SIKZBZHXHBSSEA-UHFFFAOYSA-N 1-[4-(3-fluoropiperidin-1-yl)-2,3-dihydro-1h-inden-1-yl]-3-(1h-indazol-4-yl)urea Chemical compound C1C(F)CCCN1C1=CC=CC2=C1CCC2NC(=O)NC1=CC=CC2=C1C=NN2 SIKZBZHXHBSSEA-UHFFFAOYSA-N 0.000 claims description 3
- YCVQWQOSFHWGAV-UHFFFAOYSA-N 1-[4-(4,4-difluoropiperidin-1-yl)-2,3-dihydro-1h-inden-1-yl]-3-(1h-indazol-4-yl)urea Chemical compound C1CC(F)(F)CCN1C1=CC=CC2=C1CCC2NC(=O)NC1=CC=CC2=C1C=NN2 YCVQWQOSFHWGAV-UHFFFAOYSA-N 0.000 claims description 3
- LDPUXYQORLSBQP-UHFFFAOYSA-N BrC=1C=C2CCN(C2=CC1)NC(=O)NC1=C2C=CN=CC2=CC=C1 Chemical compound BrC=1C=C2CCN(C2=CC1)NC(=O)NC1=C2C=CN=CC2=CC=C1 LDPUXYQORLSBQP-UHFFFAOYSA-N 0.000 claims description 3
- GJEHLSQOOZTIGK-UHFFFAOYSA-N C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=C(C=CC=C12)OC(F)(F)F Chemical compound C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=C(C=CC=C12)OC(F)(F)F GJEHLSQOOZTIGK-UHFFFAOYSA-N 0.000 claims description 3
- FDUSASRINVTKIT-UHFFFAOYSA-N C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=CC=C(C=C12)C Chemical compound C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=CC=C(C=C12)C FDUSASRINVTKIT-UHFFFAOYSA-N 0.000 claims description 3
- ODRNCDWPBLRBQT-UHFFFAOYSA-N C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=CC=C(C=C12)F Chemical compound C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=CC=C(C=C12)F ODRNCDWPBLRBQT-UHFFFAOYSA-N 0.000 claims description 3
- QAAXYDRVAKOQAD-UHFFFAOYSA-N C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=CC=CC(=C12)C Chemical compound C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=CC=CC(=C12)C QAAXYDRVAKOQAD-UHFFFAOYSA-N 0.000 claims description 3
- CIDIBYJIJFUPQR-UHFFFAOYSA-N COC=1C=C2CCN(C2=CC1OC)NC(=O)NC1=C2C=NNC2=CC=C1 Chemical compound COC=1C=C2CCN(C2=CC1OC)NC(=O)NC1=C2C=NNC2=CC=C1 CIDIBYJIJFUPQR-UHFFFAOYSA-N 0.000 claims description 3
- ROYPPXGJJBYESZ-UHFFFAOYSA-N ClC1=C2CCN(C2=CC=C1)NC(=O)NC1=C2C=NNC2=CC=C1 Chemical compound ClC1=C2CCN(C2=CC=C1)NC(=O)NC1=C2C=NNC2=CC=C1 ROYPPXGJJBYESZ-UHFFFAOYSA-N 0.000 claims description 3
- LUGHMUGEDZFKKY-UHFFFAOYSA-N ClC=1C=C2CCN(C2=CC1)NC(=O)NC1=C2C=NNC2=CC=C1 Chemical compound ClC=1C=C2CCN(C2=CC1)NC(=O)NC1=C2C=NNC2=CC=C1 LUGHMUGEDZFKKY-UHFFFAOYSA-N 0.000 claims description 3
- ZAMABONHWDIEAV-UHFFFAOYSA-N FC1=C(C=C2CCN(C2=C1)NC(=O)NC1=C2C=NNC2=CC=C1)N1CCCCC1 Chemical compound FC1=C(C=C2CCN(C2=C1)NC(=O)NC1=C2C=NNC2=CC=C1)N1CCCCC1 ZAMABONHWDIEAV-UHFFFAOYSA-N 0.000 claims description 3
- JPKRTXQWMWHCSI-UHFFFAOYSA-N N1(CCCCC1)C1CCN(CC1)C=1C=C2CCN(C2=CC1)NC(=O)NC1=C2C=NNC2=CC=C1 Chemical compound N1(CCCCC1)C1CCN(CC1)C=1C=C2CCN(C2=CC1)NC(=O)NC1=C2C=NNC2=CC=C1 JPKRTXQWMWHCSI-UHFFFAOYSA-N 0.000 claims description 3
- CDSFTOLCFNWVMB-UHFFFAOYSA-N N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=C(C=CC=C12)C1=CC=NC=C1 Chemical compound N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=C(C=CC=C12)C1=CC=NC=C1 CDSFTOLCFNWVMB-UHFFFAOYSA-N 0.000 claims description 3
- YGEDZVIBQQMWTK-UHFFFAOYSA-N N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=C(C=CC=C12)C=1C=NC=CC1 Chemical compound N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=C(C=CC=C12)C=1C=NC=CC1 YGEDZVIBQQMWTK-UHFFFAOYSA-N 0.000 claims description 3
- YMWLDVFKKCOYMY-UHFFFAOYSA-N N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=CC(=CC=C12)N1C(CCCC1)=O Chemical compound N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=CC(=CC=C12)N1C(CCCC1)=O YMWLDVFKKCOYMY-UHFFFAOYSA-N 0.000 claims description 3
- HGBHQYSMMDDYKN-UHFFFAOYSA-N N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=CC(=CC=C12)N1CC(CCC1)C Chemical compound N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=CC(=CC=C12)N1CC(CCC1)C HGBHQYSMMDDYKN-UHFFFAOYSA-N 0.000 claims description 3
- 125000004429 atom Chemical group 0.000 claims description 3
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 claims description 3
- 125000000392 cycloalkenyl group Chemical group 0.000 claims description 3
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 claims description 3
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 claims description 3
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 claims description 3
- MGALILGJTHFPJG-UHFFFAOYSA-N C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=C(C=CC=C12)N1CCCCC1 Chemical compound C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=C(C=CC=C12)N1CCCCC1 MGALILGJTHFPJG-UHFFFAOYSA-N 0.000 claims description 2
- 150000001555 benzenes Chemical class 0.000 claims description 2
- 238000012545 processing Methods 0.000 claims description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 claims 2
- PKVCREBZFWTVRQ-UHFFFAOYSA-N 1-(1h-indazol-4-yl)-3-(4-pyridin-2-yl-2,3-dihydro-1h-inden-1-yl)urea Chemical compound C=1C=CC=2NN=CC=2C=1NC(=O)NC1CCC2=C1C=CC=C2C1=CC=CC=N1 PKVCREBZFWTVRQ-UHFFFAOYSA-N 0.000 claims 1
- WIPBDFYJQOHJLH-UHFFFAOYSA-N C(C)(C)(C)C=1C=C2CCN(C2=CC1)NC(=O)NC=1C=CCC2=NC3=CC=CC=C3C12 Chemical compound C(C)(C)(C)C=1C=C2CCN(C2=CC1)NC(=O)NC=1C=CCC2=NC3=CC=CC=C3C12 WIPBDFYJQOHJLH-UHFFFAOYSA-N 0.000 claims 1
- DVIGGPSDTCGLRR-UHFFFAOYSA-N C(C)C1C(=CC2=CC=CC=C12)N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=CC(=C(C=C12)OC)OC Chemical compound C(C)C1C(=CC2=CC=CC=C12)N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=CC(=C(C=C12)OC)OC DVIGGPSDTCGLRR-UHFFFAOYSA-N 0.000 claims 1
- FENHHJQRBUCGLB-UHFFFAOYSA-N C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=CC(=CC=C12)C(F)(F)F Chemical compound C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=CC(=CC=C12)C(F)(F)F FENHHJQRBUCGLB-UHFFFAOYSA-N 0.000 claims 1
- PICKCQMOSPNEAG-UHFFFAOYSA-N FC1CCN(CC1)C1=C2CCC(C2=CC=C1)NC(=O)NC=1C=CCC2=NC3=CC=CC=C3C12 Chemical compound FC1CCN(CC1)C1=C2CCC(C2=CC=C1)NC(=O)NC=1C=CCC2=NC3=CC=CC=C3C12 PICKCQMOSPNEAG-UHFFFAOYSA-N 0.000 claims 1
- AEKIYVBCIZLYQU-UHFFFAOYSA-N N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=C(C=CC=C12)N1CC2CCCCC2CC1 Chemical compound N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=C(C=CC=C12)N1CC2CCCCC2CC1 AEKIYVBCIZLYQU-UHFFFAOYSA-N 0.000 claims 1
- GYSAZCVLSNOBBR-UHFFFAOYSA-N N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=C(C=CC=C12)N1CCOCC1 Chemical compound N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=C(C=CC=C12)N1CCOCC1 GYSAZCVLSNOBBR-UHFFFAOYSA-N 0.000 claims 1
- YRSFOOLUIIQCMD-UHFFFAOYSA-N N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=CC(=CC=C12)N1C(CCCC1)C Chemical compound N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=CC(=CC=C12)N1C(CCCC1)C YRSFOOLUIIQCMD-UHFFFAOYSA-N 0.000 claims 1
- 241000009298 Trigla lyra Species 0.000 claims 1
- 125000005278 alkyl sulfonyloxy group Chemical group 0.000 claims 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 9
- 241000124008 Mammalia Species 0.000 abstract description 5
- 238000005481 NMR spectroscopy Methods 0.000 description 137
- 239000000243 solution Substances 0.000 description 76
- 235000019439 ethyl acetate Nutrition 0.000 description 72
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 66
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 61
- 239000007787 solid Substances 0.000 description 56
- 238000010511 deprotection reaction Methods 0.000 description 50
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 44
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 39
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 38
- 238000004458 analytical method Methods 0.000 description 36
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 34
- 239000011541 reaction mixture Substances 0.000 description 32
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 28
- 239000000047 product Substances 0.000 description 25
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 24
- 238000000921 elemental analysis Methods 0.000 description 24
- 150000001412 amines Chemical class 0.000 description 23
- 239000002585 base Substances 0.000 description 22
- 239000012044 organic layer Substances 0.000 description 22
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 22
- IIJPVOVAVTZFRH-UHFFFAOYSA-N 5-tert-butyl-2,3-dihydroinden-1-one Chemical compound CC(C)(C)C1=CC=C2C(=O)CCC2=C1 IIJPVOVAVTZFRH-UHFFFAOYSA-N 0.000 description 20
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 20
- 229960000583 acetic acid Drugs 0.000 description 20
- 239000003921 oil Substances 0.000 description 20
- 235000019198 oils Nutrition 0.000 description 20
- 230000002829 reductive effect Effects 0.000 description 20
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N DMSO Substances CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 19
- 235000017663 capsaicin Nutrition 0.000 description 18
- 229960002504 capsaicin Drugs 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 17
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 16
- DIIIISSCIXVANO-UHFFFAOYSA-N 1,2-Dimethylhydrazine Chemical compound CNNC DIIIISSCIXVANO-UHFFFAOYSA-N 0.000 description 15
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 14
- OJCSPXHYDFONPU-UHFFFAOYSA-N etoac etoac Chemical compound CCOC(C)=O.CCOC(C)=O OJCSPXHYDFONPU-UHFFFAOYSA-N 0.000 description 14
- 239000000706 filtrate Substances 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 13
- 239000000463 material Substances 0.000 description 13
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 12
- 239000012065 filter cake Substances 0.000 description 12
- 238000001914 filtration Methods 0.000 description 12
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 12
- 238000000926 separation method Methods 0.000 description 12
- 238000004128 high performance liquid chromatography Methods 0.000 description 11
- 238000003756 stirring Methods 0.000 description 11
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 10
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 10
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 10
- IFHJHFNIGDYOMH-UHFFFAOYSA-N C(C)(C)(C)C=1C=C2CC(N(C2=CC1)NC(=O)NC1=C2C=NNC2=CC=C1)F Chemical compound C(C)(C)(C)C=1C=C2CC(N(C2=CC1)NC(=O)NC1=C2C=NNC2=CC=C1)F IFHJHFNIGDYOMH-UHFFFAOYSA-N 0.000 description 10
- 239000003054 catalyst Substances 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- 238000010992 reflux Methods 0.000 description 10
- 239000000725 suspension Substances 0.000 description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 238000001816 cooling Methods 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 150000002148 esters Chemical class 0.000 description 9
- 239000010410 layer Substances 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 108091006146 Channels Proteins 0.000 description 8
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 8
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 8
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 8
- 238000002441 X-ray diffraction Methods 0.000 description 8
- 238000000113 differential scanning calorimetry Methods 0.000 description 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 8
- 239000002244 precipitate Substances 0.000 description 8
- 108020003175 receptors Proteins 0.000 description 8
- OBRBVANDVAPEDW-UHFFFAOYSA-N CC(CCCC1)N1C(C=C1CC2)=CC=C1N2N Chemical compound CC(CCCC1)N1C(C=C1CC2)=CC=C1N2N OBRBVANDVAPEDW-UHFFFAOYSA-N 0.000 description 7
- HAFQCVSRDIVLPA-UHFFFAOYSA-N O=C(NC1=C(C=NN2)C2=CC=C1)NN1C2=CC=CC(N3CCCCC3)=C2CC1 Chemical compound O=C(NC1=C(C=NN2)C2=CC=C1)NN1C2=CC=CC(N3CCCCC3)=C2CC1 HAFQCVSRDIVLPA-UHFFFAOYSA-N 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 239000011575 calcium Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 7
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 6
- KCABKPVNWUANHN-UHFFFAOYSA-N CC(C)(C(C=C1CC2)=CC=C1N2NC(NC1=C(C=NN2)C2=CC=C1)=O)C#N Chemical compound CC(C)(C(C=C1CC2)=CC=C1N2NC(NC1=C(C=NN2)C2=CC=C1)=O)C#N KCABKPVNWUANHN-UHFFFAOYSA-N 0.000 description 6
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 6
- 238000004821 distillation Methods 0.000 description 6
- 150000002466 imines Chemical class 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000002502 liposome Substances 0.000 description 6
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 6
- 235000019341 magnesium sulphate Nutrition 0.000 description 6
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 description 6
- 150000003335 secondary amines Chemical class 0.000 description 6
- NKECRCMIFURWMK-UHFFFAOYSA-N 2-(3-bromophenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)C1=CC=CC(Br)=C1 NKECRCMIFURWMK-UHFFFAOYSA-N 0.000 description 5
- DTVYNUOOZIKEEX-UHFFFAOYSA-N 5-aminoisoquinoline Chemical class N1=CC=C2C(N)=CC=CC2=C1 DTVYNUOOZIKEEX-UHFFFAOYSA-N 0.000 description 5
- QALFNOOQHVZTLE-UHFFFAOYSA-N CC(C)(C)C(C=C1CC2)=CC=C1N2N Chemical compound CC(C)(C)C(C=C1CC2)=CC=C1N2N QALFNOOQHVZTLE-UHFFFAOYSA-N 0.000 description 5
- 229910004373 HOAc Inorganic materials 0.000 description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- VDEPCBBVWRWYNQ-UHFFFAOYSA-N N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=CC(=CC=C12)OC Chemical compound N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=CC(=CC=C12)OC VDEPCBBVWRWYNQ-UHFFFAOYSA-N 0.000 description 5
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 5
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 5
- 244000290333 Vanilla fragrans Species 0.000 description 5
- 235000009499 Vanilla fragrans Nutrition 0.000 description 5
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 5
- 229910021529 ammonia Inorganic materials 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- 230000008602 contraction Effects 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 239000003937 drug carrier Substances 0.000 description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 231100000252 nontoxic Toxicity 0.000 description 5
- 230000003000 nontoxic effect Effects 0.000 description 5
- 125000004430 oxygen atom Chemical group O* 0.000 description 5
- 229910052763 palladium Inorganic materials 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 125000003396 thiol group Chemical class [H]S* 0.000 description 5
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 4
- CBWPQIOBBJWRKM-UHFFFAOYSA-N 4-(4,4-difluoropiperidin-1-yl)-2,3-dihydroindol-1-amine Chemical compound FC1(CCN(CC1)C1=C2CCN(C2=CC=C1)N)F CBWPQIOBBJWRKM-UHFFFAOYSA-N 0.000 description 4
- UVVYFYLSZIMKMC-UHFFFAOYSA-N 4-bromo-2,3-dihydroinden-1-one Chemical compound BrC1=CC=CC2=C1CCC2=O UVVYFYLSZIMKMC-UHFFFAOYSA-N 0.000 description 4
- NZJBXPIDQMWXCI-UHFFFAOYSA-N 4-methyl-2,3-dihydroindol-1-amine Chemical compound CC1=CC=CC2=C1CCN2N NZJBXPIDQMWXCI-UHFFFAOYSA-N 0.000 description 4
- RCPFHUXEZIREGX-UHFFFAOYSA-N 5-(1-methoxy-2-methylpropan-2-yl)-2,3-dihydro-1h-inden-1-amine Chemical compound COCC(C)(C)C1=CC=C2C(N)CCC2=C1 RCPFHUXEZIREGX-UHFFFAOYSA-N 0.000 description 4
- JYRVCRJPCWMDQT-UHFFFAOYSA-N 5-tert-butyl-2,3-dihydro-1h-inden-1-amine Chemical compound CC(C)(C)C1=CC=C2C(N)CCC2=C1 JYRVCRJPCWMDQT-UHFFFAOYSA-N 0.000 description 4
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 4
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 4
- ADFWSEMRJXWNEV-UHFFFAOYSA-N C1CN(C2=CC=CC(=C21)C(F)(F)F)N Chemical compound C1CN(C2=CC=CC(=C21)C(F)(F)F)N ADFWSEMRJXWNEV-UHFFFAOYSA-N 0.000 description 4
- HFBOLIJWYPOSHX-UHFFFAOYSA-N CC(CC1)CCN1C1=C(CCN2NC(NC3=C4C5=CC=CC=C5N=C4CC=C3)=O)C2=CC=C1 Chemical compound CC(CC1)CCN1C1=C(CCN2NC(NC3=C4C5=CC=CC=C5N=C4CC=C3)=O)C2=CC=C1 HFBOLIJWYPOSHX-UHFFFAOYSA-N 0.000 description 4
- MFLUZWYKMNMNMV-UHFFFAOYSA-N CC1=CC=C(CCN2NC(NC3=C(C=NN4C(OC)=O)C4=CC=C3)=O)C2=C1 Chemical compound CC1=CC=C(CCN2NC(NC3=C(C=NN4C(OC)=O)C4=CC=C3)=O)C2=C1 MFLUZWYKMNMNMV-UHFFFAOYSA-N 0.000 description 4
- WXYLLTSYRANJRB-UHFFFAOYSA-N CC1CCCN(C1)C2=C3CCN(C3=CC=C2)N Chemical compound CC1CCCN(C1)C2=C3CCN(C3=CC=C2)N WXYLLTSYRANJRB-UHFFFAOYSA-N 0.000 description 4
- KPABSCXWPAXTFG-UHFFFAOYSA-N CC1CCN(CC1)C2=CC3=C(C=C2)N(CC3)N Chemical compound CC1CCN(CC1)C2=CC3=C(C=C2)N(CC3)N KPABSCXWPAXTFG-UHFFFAOYSA-N 0.000 description 4
- JCTMRSSNEVRVLT-UHFFFAOYSA-N CC1N(CCC1)C1=C2CCN(C2=CC=C1)N Chemical compound CC1N(CCC1)C1=C2CCN(C2=CC=C1)N JCTMRSSNEVRVLT-UHFFFAOYSA-N 0.000 description 4
- RCPCPTUVSXIFGX-UHFFFAOYSA-N COC(N(C1=CC=C2)N=CC1=C2NC(NN1C2=CC(F)=CC=C2CC1)=O)=O Chemical compound COC(N(C1=CC=C2)N=CC1=C2NC(NN1C2=CC(F)=CC=C2CC1)=O)=O RCPCPTUVSXIFGX-UHFFFAOYSA-N 0.000 description 4
- MHZGKXUYDGKKIU-UHFFFAOYSA-N Decylamine Chemical compound CCCCCCCCCCN MHZGKXUYDGKKIU-UHFFFAOYSA-N 0.000 description 4
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- DUWPOWOPNNBGHR-UHFFFAOYSA-N NN(CCC1=C2)C1=CC=C2N(CC1)CCC1C(F)(F)F Chemical compound NN(CCC1=C2)C1=CC=C2N(CC1)CCC1C(F)(F)F DUWPOWOPNNBGHR-UHFFFAOYSA-N 0.000 description 4
- FCCQUEUIDKAZIE-UHFFFAOYSA-N NN(CCC1=C2)C1=CC=C2N(CCCC1)C1=O Chemical compound NN(CCC1=C2)C1=CC=C2N(CCCC1)C1=O FCCQUEUIDKAZIE-UHFFFAOYSA-N 0.000 description 4
- KLWDTKCPQMWNPT-UHFFFAOYSA-N NN1C2=CC=CC(N(CCC3)CC3(F)F)=C2CC1 Chemical compound NN1C2=CC=CC(N(CCC3)CC3(F)F)=C2CC1 KLWDTKCPQMWNPT-UHFFFAOYSA-N 0.000 description 4
- AWIISUXIYAWRSH-UHFFFAOYSA-N NN1C2=CC=CC(N(CCC3)CC3F)=C2CC1 Chemical compound NN1C2=CC=CC(N(CCC3)CC3F)=C2CC1 AWIISUXIYAWRSH-UHFFFAOYSA-N 0.000 description 4
- ASOPJJSEGOTZGZ-UHFFFAOYSA-N NN1C2=CC=CC(N3CC(CCCC4)C4CC3)=C2CC1 Chemical compound NN1C2=CC=CC(N3CC(CCCC4)C4CC3)=C2CC1 ASOPJJSEGOTZGZ-UHFFFAOYSA-N 0.000 description 4
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 4
- 230000003502 anti-nociceptive effect Effects 0.000 description 4
- HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical compound CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 description 4
- 125000004122 cyclic group Chemical group 0.000 description 4
- 229960003750 ethyl chloride Drugs 0.000 description 4
- 239000012458 free base Substances 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 125000005843 halogen group Chemical group 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 150000003840 hydrochlorides Chemical class 0.000 description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 4
- XNXVOSBNFZWHBV-UHFFFAOYSA-N hydron;o-methylhydroxylamine;chloride Chemical compound Cl.CON XNXVOSBNFZWHBV-UHFFFAOYSA-N 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- QNXSIUBBGPHDDE-UHFFFAOYSA-N indan-1-one Chemical compound C1=CC=C2C(=O)CCC2=C1 QNXSIUBBGPHDDE-UHFFFAOYSA-N 0.000 description 4
- 230000002757 inflammatory effect Effects 0.000 description 4
- 239000012948 isocyanate Substances 0.000 description 4
- 150000002513 isocyanates Chemical class 0.000 description 4
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- CKTCGUBUWFAJBZ-UHFFFAOYSA-N methyl 4-nitroindazole-1-carboxylate Chemical compound C1=CC=C2N(C(=O)OC)N=CC2=C1[N+]([O-])=O CKTCGUBUWFAJBZ-UHFFFAOYSA-N 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- 239000002002 slurry Substances 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- LRGZZEOWQURWFK-UHFFFAOYSA-N 1,2,3,4,4a,5,6,7-octahydroisoquinoline Chemical compound C1NCCC2CCCC=C21 LRGZZEOWQURWFK-UHFFFAOYSA-N 0.000 description 3
- RWKVKFPYVTZRHS-UHFFFAOYSA-N 1-(4-tert-butylphenyl)-3-chloropropan-1-one Chemical compound CC(C)(C)C1=CC=C(C(=O)CCCl)C=C1 RWKVKFPYVTZRHS-UHFFFAOYSA-N 0.000 description 3
- VYOKOQDVBBWPKO-UHFFFAOYSA-N 1-nitro-9h-carbazole Chemical compound N1C2=CC=CC=C2C2=C1C([N+](=O)[O-])=CC=C2 VYOKOQDVBBWPKO-UHFFFAOYSA-N 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- UPQQXPKAYZYUKO-UHFFFAOYSA-N 2,2,2-trichloroacetamide Chemical compound OC(=N)C(Cl)(Cl)Cl UPQQXPKAYZYUKO-UHFFFAOYSA-N 0.000 description 3
- XJEVHMGJSYVQBQ-UHFFFAOYSA-N 2,3-dihydro-1h-inden-1-amine Chemical compound C1=CC=C2C(N)CCC2=C1 XJEVHMGJSYVQBQ-UHFFFAOYSA-N 0.000 description 3
- CHBHPICKRBKWAE-UHFFFAOYSA-N 4-(2-methylpiperidin-1-yl)-2,3-dihydro-1h-inden-1-amine Chemical compound CC1CCCCN1C1=CC=CC2=C1CCC2N CHBHPICKRBKWAE-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
- PAPAFYYMTYRHPR-UHFFFAOYSA-N C12CCCC(CC1)N2C=2C=C1CCN(C1=CC2)N Chemical compound C12CCCC(CC1)N2C=2C=C1CCN(C1=CC2)N PAPAFYYMTYRHPR-UHFFFAOYSA-N 0.000 description 3
- YTVXYGYENFGXOC-UHFFFAOYSA-N C12N(CC(CC1)C2)C=2C=C1CCN(C1=CC2)N Chemical compound C12N(CC(CC1)C2)C=2C=C1CCN(C1=CC2)N YTVXYGYENFGXOC-UHFFFAOYSA-N 0.000 description 3
- JUHYOSANUDGSEY-UHFFFAOYSA-N C1N(CCC2CCCCC12)C=1C=C2CCN(C2=CC1)N Chemical compound C1N(CCC2CCCCC12)C=1C=C2CCN(C2=CC1)N JUHYOSANUDGSEY-UHFFFAOYSA-N 0.000 description 3
- FTYZAVSCNAQIOL-UHFFFAOYSA-N CC(C)(C)C(C=C1CC2)=CC=C1N2NC(NC1=C(C=NN2C(OC)=O)C2=CC=C1)=O Chemical compound CC(C)(C)C(C=C1CC2)=CC=C1N2NC(NC1=C(C=NN2C(OC)=O)C2=CC=C1)=O FTYZAVSCNAQIOL-UHFFFAOYSA-N 0.000 description 3
- FKCHRHQUDPONFE-UHFFFAOYSA-N CC(C)(C)CCCCCCCCCC1=CC=CC(C(C)(C)C#N)=C1C#C Chemical compound CC(C)(C)CCCCCCCCCC1=CC=CC(C(C)(C)C#N)=C1C#C FKCHRHQUDPONFE-UHFFFAOYSA-N 0.000 description 3
- VSVPVHOZWIWWFR-UHFFFAOYSA-N CC1CN(CC(O1)C)C=1C=C2CCN(C2=CC1)N Chemical compound CC1CN(CC(O1)C)C=1C=C2CCN(C2=CC1)N VSVPVHOZWIWWFR-UHFFFAOYSA-N 0.000 description 3
- ATIKJRDPYFCZNW-UHFFFAOYSA-N COC(=O)N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=CC(=C(C=C12)F)N1CCCCC1 Chemical compound COC(=O)N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=CC(=C(C=C12)F)N1CCCCC1 ATIKJRDPYFCZNW-UHFFFAOYSA-N 0.000 description 3
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 3
- 239000004215 Carbon black (E152) Substances 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 3
- IKMWPZBSNKTXCK-UHFFFAOYSA-N FC1CCN(CC1)C=1C=C2CCN(C2=CC1)N Chemical compound FC1CCN(CC1)C=1C=C2CCN(C2=CC1)N IKMWPZBSNKTXCK-UHFFFAOYSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- CDHYBPPHUXWBHS-UHFFFAOYSA-N NN(CCC1=C2)C1=CC=C2N(CC1)CCC1C1=CC=CC=C1 Chemical compound NN(CCC1=C2)C1=CC=C2N(CC1)CCC1C1=CC=CC=C1 CDHYBPPHUXWBHS-UHFFFAOYSA-N 0.000 description 3
- LZASIXMEGDDDEZ-UHFFFAOYSA-N NN1C2=CC=CC(N3CCCCC3)=C2CC1 Chemical compound NN1C2=CC=CC(N3CCCCC3)=C2CC1 LZASIXMEGDDDEZ-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 108010062740 TRPV Cation Channels Proteins 0.000 description 3
- 102000011040 TRPV Cation Channels Human genes 0.000 description 3
- 230000003187 abdominal effect Effects 0.000 description 3
- QOMNQGZXFYNBNG-UHFFFAOYSA-N acetyloxymethyl 2-[2-[2-[5-[3-(acetyloxymethoxy)-2,7-difluoro-6-oxoxanthen-9-yl]-2-[bis[2-(acetyloxymethoxy)-2-oxoethyl]amino]phenoxy]ethoxy]-n-[2-(acetyloxymethoxy)-2-oxoethyl]-4-methylanilino]acetate Chemical compound CC(=O)OCOC(=O)CN(CC(=O)OCOC(C)=O)C1=CC=C(C)C=C1OCCOC1=CC(C2=C3C=C(F)C(=O)C=C3OC3=CC(OCOC(C)=O)=C(F)C=C32)=CC=C1N(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O QOMNQGZXFYNBNG-UHFFFAOYSA-N 0.000 description 3
- 235000010419 agar Nutrition 0.000 description 3
- 235000010443 alginic acid Nutrition 0.000 description 3
- 229920000615 alginic acid Polymers 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 125000002619 bicyclic group Chemical group 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 150000001721 carbon Chemical group 0.000 description 3
- 229910002091 carbon monoxide Inorganic materials 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 239000013058 crude material Substances 0.000 description 3
- 239000010779 crude oil Substances 0.000 description 3
- 230000003111 delayed effect Effects 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000013355 food flavoring agent Nutrition 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 230000028161 membrane depolarization Effects 0.000 description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 3
- 229910052759 nickel Inorganic materials 0.000 description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 description 3
- 230000001473 noxious effect Effects 0.000 description 3
- 239000004006 olive oil Substances 0.000 description 3
- 235000008390 olive oil Nutrition 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 150000003904 phospholipids Chemical class 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 229920000137 polyphosphoric acid Polymers 0.000 description 3
- 229960004063 propylene glycol Drugs 0.000 description 3
- 239000002464 receptor antagonist Substances 0.000 description 3
- 229940044551 receptor antagonist Drugs 0.000 description 3
- 238000001896 rotating frame Overhauser effect spectroscopy Methods 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000007909 solid dosage form Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000012258 stirred mixture Substances 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 239000000829 suppository Substances 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 description 2
- NKPHNCDXJTYHLB-UHFFFAOYSA-N 1-(1H-indazol-4-yl)-3-[4-(trifluoromethyl)-2,3-dihydroindol-1-yl]urea Chemical compound N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=C(C=CC=C12)C(F)(F)F NKPHNCDXJTYHLB-UHFFFAOYSA-N 0.000 description 2
- NDELKAAQXJLUHP-UHFFFAOYSA-N 1-(5-tert-butyl-2,2-difluoro-3H-indol-1-yl)-3-(1H-indazol-4-yl)urea Chemical compound C(C)(C)(C)C=1C=C2CC(N(C2=CC1)NC(=O)NC1=C2C=NNC2=CC=C1)(F)F NDELKAAQXJLUHP-UHFFFAOYSA-N 0.000 description 2
- MNELSNAYLAVDIE-UHFFFAOYSA-N 1-(6,7-dihydro-5h-cyclopenta[b]pyridin-7-yl)-3-(1h-indazol-4-yl)urea Chemical compound C1CC2=CC=CN=C2C1NC(=O)NC1=CC=CC2=C1C=NN2 MNELSNAYLAVDIE-UHFFFAOYSA-N 0.000 description 2
- SBVPKBZNKRFVGA-OAHLLOKOSA-N 1-[(1r)-5-chloro-2,3-dihydro-1h-inden-1-yl]-3-(1h-indazol-4-yl)urea Chemical compound N([C@H]1C2=CC=C(C=C2CC1)Cl)C(=O)NC1=CC=CC2=C1C=NN2 SBVPKBZNKRFVGA-OAHLLOKOSA-N 0.000 description 2
- XFMUCOATRRXTLZ-UHFFFAOYSA-N 1-[4-(2,6-dimethylmorpholin-4-yl)-2,3-dihydro-1h-inden-1-yl]-3-(1h-indazol-4-yl)urea Chemical compound C1C(C)OC(C)CN1C1=CC=CC2=C1CCC2NC(=O)NC1=CC=CC2=C1C=NN2 XFMUCOATRRXTLZ-UHFFFAOYSA-N 0.000 description 2
- FGZOWQBNDORKQL-UHFFFAOYSA-N 1-[5-(2-cyanopropan-2-yl)-2,3-dihydro-1h-inden-1-yl]-3-(1h-indazol-4-yl)urea Chemical compound C1CC2=CC(C(C)(C#N)C)=CC=C2C1NC(=O)NC1=CC=CC2=C1C=NN2 FGZOWQBNDORKQL-UHFFFAOYSA-N 0.000 description 2
- HONYEGOQNAXWBY-UHFFFAOYSA-N 1-bromo-3-(1-methoxy-2-methylpropan-2-yl)benzene Chemical compound COCC(C)(C)C1=CC=CC(Br)=C1 HONYEGOQNAXWBY-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- NNWUEBIEOFQMSS-UHFFFAOYSA-N 2-Methylpiperidine Chemical compound CC1CCCCN1 NNWUEBIEOFQMSS-UHFFFAOYSA-N 0.000 description 2
- IDWZRJQMSBEVIW-UHFFFAOYSA-N 2-methyl-2-(1-oxo-2,3-dihydroinden-5-yl)propanenitrile Chemical compound N#CC(C)(C)C1=CC=C2C(=O)CCC2=C1 IDWZRJQMSBEVIW-UHFFFAOYSA-N 0.000 description 2
- VWXVTHDQAOAENP-UHFFFAOYSA-N 3-(3-methylphenyl)propanoic acid Chemical compound CC1=CC=CC(CCC(O)=O)=C1 VWXVTHDQAOAENP-UHFFFAOYSA-N 0.000 description 2
- JEGMWWXJUXDNJN-UHFFFAOYSA-N 3-methylpiperidine Chemical compound CC1CCCNC1 JEGMWWXJUXDNJN-UHFFFAOYSA-N 0.000 description 2
- IPXSTUAVYOBPIM-UHFFFAOYSA-N 4-chloro-2,3-dihydroindol-1-amine Chemical compound NN1CCc2c1cccc2Cl IPXSTUAVYOBPIM-UHFFFAOYSA-N 0.000 description 2
- UZOFELREXGAFOI-UHFFFAOYSA-N 4-methylpiperidine Chemical compound CC1CCNCC1 UZOFELREXGAFOI-UHFFFAOYSA-N 0.000 description 2
- FJCQVBCDARVARX-UHFFFAOYSA-N 4-nitro-1H-carbazole Chemical compound [N+](=O)([O-])C=1C=CCC2=NC3=CC=CC=C3C=12 FJCQVBCDARVARX-UHFFFAOYSA-N 0.000 description 2
- VFFDVXBDFBHFMF-UHFFFAOYSA-N 5-(1-methoxy-2-methylpropan-2-yl)-2,3-dihydroinden-1-one Chemical compound COCC(C)(C)C1=CC=C2C(=O)CCC2=C1 VFFDVXBDFBHFMF-UHFFFAOYSA-N 0.000 description 2
- JAVMRYUQNRFNMQ-UHFFFAOYSA-N 5-bromo-n-methoxy-2,3-dihydroinden-1-imine Chemical compound BrC1=CC=C2C(=NOC)CCC2=C1 JAVMRYUQNRFNMQ-UHFFFAOYSA-N 0.000 description 2
- PHSCZLWBNAKWML-UHFFFAOYSA-N 5-chloro-2,3-dihydroindol-1-amine Chemical compound ClC1=CC=C2N(N)CCC2=C1 PHSCZLWBNAKWML-UHFFFAOYSA-N 0.000 description 2
- WVPPBVAMKNQXJA-UHFFFAOYSA-N 5-fluoro-2,3-dihydroinden-1-one Chemical compound FC1=CC=C2C(=O)CCC2=C1 WVPPBVAMKNQXJA-UHFFFAOYSA-N 0.000 description 2
- RKKAIOIGGMEYDV-UHFFFAOYSA-N 5-methyl-2,3-dihydroindol-1-amine Chemical compound CC1=CC=C2N(N)CCC2=C1 RKKAIOIGGMEYDV-UHFFFAOYSA-N 0.000 description 2
- JZODYNDLLAYOAY-UHFFFAOYSA-N 5-tert-butyl-2,2-difluoro-3h-inden-1-one Chemical compound CC(C)(C)C1=CC=C2C(=O)C(F)(F)CC2=C1 JZODYNDLLAYOAY-UHFFFAOYSA-N 0.000 description 2
- DCWWFXGCBMZVFC-UHFFFAOYSA-N 5-tert-butyl-2,3-dihydro-1h-indole Chemical compound CC(C)(C)C1=CC=C2NCCC2=C1 DCWWFXGCBMZVFC-UHFFFAOYSA-N 0.000 description 2
- LUTNMQJQPDHDTE-UHFFFAOYSA-N 5-tert-butyl-2-fluoro-2,3-dihydroinden-1-one Chemical compound CC(C)(C)C1=CC=C2C(=O)C(F)CC2=C1 LUTNMQJQPDHDTE-UHFFFAOYSA-N 0.000 description 2
- YXFBUHKJKDIRRN-UHFFFAOYSA-N 6-fluoro-2,3-dihydroindol-1-amine Chemical compound C1=C(F)C=C2N(N)CCC2=C1 YXFBUHKJKDIRRN-UHFFFAOYSA-N 0.000 description 2
- RBZDMSFSRCQAFA-UHFFFAOYSA-N 7-methyl-2,3-dihydroindol-1-amine Chemical compound CC=1C=CC=C2CCN(C=12)N RBZDMSFSRCQAFA-UHFFFAOYSA-N 0.000 description 2
- XHGKPMMTTJRQLM-UHFFFAOYSA-N 9h-carbazol-4-amine Chemical compound N1C2=CC=CC=C2C2=C1C=CC=C2N XHGKPMMTTJRQLM-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- NOXQNDDYTPALCD-UHFFFAOYSA-N BrC1=C2CCN(C2=CC=C1)NC(=O)NC1=C2C=NNC2=CC=C1 Chemical compound BrC1=C2CCN(C2=CC=C1)NC(=O)NC1=C2C=NNC2=CC=C1 NOXQNDDYTPALCD-UHFFFAOYSA-N 0.000 description 2
- 206010006298 Breast pain Diseases 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- XXLYOXMMJHDLIJ-UHFFFAOYSA-N C(C(C)C)OC(=O)N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=CC(=CC=C12)C(C)(C)C Chemical compound C(C(C)C)OC(=O)N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=CC(=CC=C12)C(C)(C)C XXLYOXMMJHDLIJ-UHFFFAOYSA-N 0.000 description 2
- KBFBIIPCZLZIRD-UHFFFAOYSA-N C(C)(C)(C)C=1C=C2CC(NC2=CC1)NC(=O)NC1=C2C=NNC2=CC=C1 Chemical compound C(C)(C)(C)C=1C=C2CC(NC2=CC1)NC(=O)NC1=C2C=NNC2=CC=C1 KBFBIIPCZLZIRD-UHFFFAOYSA-N 0.000 description 2
- MIADIQYIFPNLSW-UHFFFAOYSA-N C(C)(C)(C)C=1C=C2CCN(C2=CC1)NC(=O)NC1=C2C=NNC2=CC=C1 Chemical compound C(C)(C)(C)C=1C=C2CCN(C2=CC1)NC(=O)NC1=C2C=NNC2=CC=C1 MIADIQYIFPNLSW-UHFFFAOYSA-N 0.000 description 2
- DANVXLFWLCFUIB-UHFFFAOYSA-N C(C)(C)OC(=O)N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=CC(=CC=C12)C(C)(C)C Chemical compound C(C)(C)OC(=O)N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=CC(=CC=C12)C(C)(C)C DANVXLFWLCFUIB-UHFFFAOYSA-N 0.000 description 2
- LWSKXXKJTGAMOZ-UHFFFAOYSA-N C12CCCC(CC1)N2C2=C1CCN(C1=CC=C2)NC(=O)NC2=C1C=NNC1=CC=C2 Chemical compound C12CCCC(CC1)N2C2=C1CCN(C1=CC=C2)NC(=O)NC2=C1C=NNC1=CC=C2 LWSKXXKJTGAMOZ-UHFFFAOYSA-N 0.000 description 2
- CKOQTHJLMBHSNE-UHFFFAOYSA-N C12N(CC(CC1)C2)C2=C1CCN(C1=CC=C2)NC(=O)NC2=C1C=NNC1=CC=C2 Chemical compound C12N(CC(CC1)C2)C2=C1CCN(C1=CC=C2)NC(=O)NC2=C1C=NNC1=CC=C2 CKOQTHJLMBHSNE-UHFFFAOYSA-N 0.000 description 2
- RPDPRFONLIBOEM-UHFFFAOYSA-N C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=C(C=CC=C12)C Chemical compound C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=C(C=CC=C12)C RPDPRFONLIBOEM-UHFFFAOYSA-N 0.000 description 2
- VQDALJIHVHCKIA-UHFFFAOYSA-N C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=C(C=CC=C12)C1=NC=CC=C1 Chemical compound C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=C(C=CC=C12)C1=NC=CC=C1 VQDALJIHVHCKIA-UHFFFAOYSA-N 0.000 description 2
- SUIUSNWAJSFLND-UHFFFAOYSA-N C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=C(C=CC=C12)N1C(CCC1)C Chemical compound C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=C(C=CC=C12)N1C(CCC1)C SUIUSNWAJSFLND-UHFFFAOYSA-N 0.000 description 2
- WOTJMRYJIXSMMT-UHFFFAOYSA-N C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=C(C=CC=C12)N1C(CCCC1)C Chemical compound C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=C(C=CC=C12)N1C(CCCC1)C WOTJMRYJIXSMMT-UHFFFAOYSA-N 0.000 description 2
- FPDDNROORNPDFN-UHFFFAOYSA-N C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=C(C=CC=C12)N1CC(CCC1)C Chemical compound C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=C(C=CC=C12)N1CC(CCC1)C FPDDNROORNPDFN-UHFFFAOYSA-N 0.000 description 2
- VAKOCWXWFZEKMO-UHFFFAOYSA-N C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=C(C=CC=C12)N1CCOCC1 Chemical compound C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=C(C=CC=C12)N1CCOCC1 VAKOCWXWFZEKMO-UHFFFAOYSA-N 0.000 description 2
- DGURIOKAZQLHAK-UHFFFAOYSA-N C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=CC(=CC=C12)C Chemical compound C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=CC(=CC=C12)C DGURIOKAZQLHAK-UHFFFAOYSA-N 0.000 description 2
- YJWLMQZAMPMRDY-UHFFFAOYSA-N C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=CC(=CC=C12)C(C)C Chemical compound C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=CC(=CC=C12)C(C)C YJWLMQZAMPMRDY-UHFFFAOYSA-N 0.000 description 2
- OBDQJAXFHGILIP-UHFFFAOYSA-N C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=CC(=CC=C12)C(COC)(C)C Chemical compound C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=CC(=CC=C12)C(COC)(C)C OBDQJAXFHGILIP-UHFFFAOYSA-N 0.000 description 2
- WNMMEMLMHGVXJV-UHFFFAOYSA-N C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=CC(=CC=C12)N1C(CCCC1)C Chemical compound C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=CC(=CC=C12)N1C(CCCC1)C WNMMEMLMHGVXJV-UHFFFAOYSA-N 0.000 description 2
- SCKVGJPDRUSIOG-UHFFFAOYSA-N C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=CC(=CC=C12)N1CCC(CC1)C Chemical compound C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=CC(=CC=C12)N1CCC(CC1)C SCKVGJPDRUSIOG-UHFFFAOYSA-N 0.000 description 2
- YBXQPRQYGDFHOI-UHFFFAOYSA-N C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=CC(=CC=C12)N1CCC(CC1)C1=CC=CC=C1 Chemical compound C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=CC(=CC=C12)N1CCC(CC1)C1=CC=CC=C1 YBXQPRQYGDFHOI-UHFFFAOYSA-N 0.000 description 2
- FOKLZPYHLONTER-UHFFFAOYSA-N C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=CC(=CC=C12)OC Chemical compound C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=CC(=CC=C12)OC FOKLZPYHLONTER-UHFFFAOYSA-N 0.000 description 2
- KQTIXDIFGLIWJP-UHFFFAOYSA-N C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=CC=C(C=C12)OC Chemical compound C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=CC=C(C=C12)OC KQTIXDIFGLIWJP-UHFFFAOYSA-N 0.000 description 2
- HWTYVKPRYICRIJ-UHFFFAOYSA-N C1CCN(CC1)C2=C(C=C3C(=C2)CCN3N)F Chemical compound C1CCN(CC1)C2=C(C=C3C(=C2)CCN3N)F HWTYVKPRYICRIJ-UHFFFAOYSA-N 0.000 description 2
- MHHYCUMGRMOYCR-UHFFFAOYSA-N C1CN(C2=CC=CC(=C21)CC#N)NC(=O)NC3=CC=CC4=C3C=NN4 Chemical compound C1CN(C2=CC=CC(=C21)CC#N)NC(=O)NC3=CC=CC4=C3C=NN4 MHHYCUMGRMOYCR-UHFFFAOYSA-N 0.000 description 2
- XFDMEHHELCKHKZ-UHFFFAOYSA-N C1CN(C2=CC=CC(=C21)N3CCOCC3)N Chemical compound C1CN(C2=CC=CC(=C21)N3CCOCC3)N XFDMEHHELCKHKZ-UHFFFAOYSA-N 0.000 description 2
- CXNMRGOTDMNOEC-UHFFFAOYSA-N CC(C)(C#N)C1=CC2=C(C=C1)N(CC2)N Chemical compound CC(C)(C#N)C1=CC2=C(C=C1)N(CC2)N CXNMRGOTDMNOEC-UHFFFAOYSA-N 0.000 description 2
- FMFDKUSRJGLSKK-UHFFFAOYSA-N CC(C)(C)C(C=C1C2)=CC=C1NC2N Chemical compound CC(C)(C)C(C=C1C2)=CC=C1NC2N FMFDKUSRJGLSKK-UHFFFAOYSA-N 0.000 description 2
- JEEPQVNUOPQLJZ-UHFFFAOYSA-N CC(C)(C)C(C=C1CC2F)=CC=C1N2N Chemical compound CC(C)(C)C(C=C1CC2F)=CC=C1N2N JEEPQVNUOPQLJZ-UHFFFAOYSA-N 0.000 description 2
- UNMWOTHAHOHUIW-UHFFFAOYSA-N CC(C)C(C=C1CC2)=CC=C1N2N Chemical compound CC(C)C(C=C1CC2)=CC=C1N2N UNMWOTHAHOHUIW-UHFFFAOYSA-N 0.000 description 2
- GQDZLWQOTGSUTN-UHFFFAOYSA-N CC(CC1)CCN1C1=C(CCN2N)C2=CC=C1 Chemical compound CC(CC1)CCN1C1=C(CCN2N)C2=CC=C1 GQDZLWQOTGSUTN-UHFFFAOYSA-N 0.000 description 2
- CYTIJHHIIHBKMN-UHFFFAOYSA-N COC(N(C1=CC=C2)N=CC1=C2NC(NN1C2=CC(OC)=CC=C2CC1)=O)=O Chemical compound COC(N(C1=CC=C2)N=CC1=C2NC(NN1C2=CC(OC)=CC=C2CC1)=O)=O CYTIJHHIIHBKMN-UHFFFAOYSA-N 0.000 description 2
- OXWLQPICVSWLOH-UHFFFAOYSA-N COC1=C2CCN(C2=CC=C1OC)N Chemical compound COC1=C2CCN(C2=CC=C1OC)N OXWLQPICVSWLOH-UHFFFAOYSA-N 0.000 description 2
- GNJRYNADUPGEFF-UHFFFAOYSA-N COC=1C=C2CCN(C2=CC1OC)N Chemical compound COC=1C=C2CCN(C2=CC1OC)N GNJRYNADUPGEFF-UHFFFAOYSA-N 0.000 description 2
- QPEBMLPPOFYZHF-UHFFFAOYSA-N COCC(C)(C)C=1C=C(C=CC1)C#CC(C(C)(C)C)CCCCCCCC Chemical compound COCC(C)(C)C=1C=C(C=CC1)C#CC(C(C)(C)C)CCCCCCCC QPEBMLPPOFYZHF-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 2
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 2
- LOPLZHZOYMGCKU-UHFFFAOYSA-N FC=1C=C2CCN(C2=CC1)NC(=O)NC1=C2C=NNC2=CC=C1 Chemical compound FC=1C=C2CCN(C2=CC1)NC(=O)NC1=C2C=NNC2=CC=C1 LOPLZHZOYMGCKU-UHFFFAOYSA-N 0.000 description 2
- 241000206672 Gelidium Species 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- 229930182816 L-glutamine Natural products 0.000 description 2
- 208000006662 Mastodynia Diseases 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- PPVZMVAFLBGUIJ-UHFFFAOYSA-N N1(CCCC1)C1=C2CCN(C2=CC=C1)N Chemical compound N1(CCCC1)C1=C2CCN(C2=CC=C1)N PPVZMVAFLBGUIJ-UHFFFAOYSA-N 0.000 description 2
- JWQGKBKOAGKSLT-UHFFFAOYSA-N N1(CCCCC1)C1CCN(CC1)C=1C=C2CCN(C2=CC1)N Chemical compound N1(CCCCC1)C1CCN(CC1)C=1C=C2CCN(C2=CC1)N JWQGKBKOAGKSLT-UHFFFAOYSA-N 0.000 description 2
- VLMVVVBUFUWVFY-UHFFFAOYSA-N N1(CCCCC1)C=1C=C2CCN(C2=CC1)N Chemical compound N1(CCCCC1)C=1C=C2CCN(C2=CC1)N VLMVVVBUFUWVFY-UHFFFAOYSA-N 0.000 description 2
- BQNVNUYWKHSSJW-UHFFFAOYSA-N N1(CCCCC1)C=1C=C2CCN(C2=CC1)NC(=O)NC1=C2C=NN(C2=CC=C1)C(=O)OC Chemical compound N1(CCCCC1)C=1C=C2CCN(C2=CC1)NC(=O)NC1=C2C=NN(C2=CC=C1)C(=O)OC BQNVNUYWKHSSJW-UHFFFAOYSA-N 0.000 description 2
- KZXAUQGRBYRISR-UHFFFAOYSA-N N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=CC(=CC=C12)N1CCCCC1 Chemical compound N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=CC(=CC=C12)N1CCCCC1 KZXAUQGRBYRISR-UHFFFAOYSA-N 0.000 description 2
- LAGFSIKVMIWZJA-UHFFFAOYSA-N NN1C2=CC=CC(Br)=C2CC1 Chemical compound NN1C2=CC=CC(Br)=C2CC1 LAGFSIKVMIWZJA-UHFFFAOYSA-N 0.000 description 2
- DQRVMNLNOCISAZ-UHFFFAOYSA-N NN1C2=CC=CC(C3=CC=CN=C3)=C2CC1 Chemical compound NN1C2=CC=CC(C3=CC=CN=C3)=C2CC1 DQRVMNLNOCISAZ-UHFFFAOYSA-N 0.000 description 2
- IRZAHVNUGROXHC-UHFFFAOYSA-N NN1C2=CC=CC(C3=CC=NC=C3)=C2CC1 Chemical compound NN1C2=CC=CC(C3=CC=NC=C3)=C2CC1 IRZAHVNUGROXHC-UHFFFAOYSA-N 0.000 description 2
- RKKUTNRDIMJBPB-UHFFFAOYSA-N NN1C2=CC=CC(C3=NC=CC=C3)=C2CC1 Chemical compound NN1C2=CC=CC(C3=NC=CC=C3)=C2CC1 RKKUTNRDIMJBPB-UHFFFAOYSA-N 0.000 description 2
- IXGVPSOEOVKHBN-UHFFFAOYSA-N NN1C2=CC=CC(OC(F)(F)F)=C2CC1 Chemical compound NN1C2=CC=CC(OC(F)(F)F)=C2CC1 IXGVPSOEOVKHBN-UHFFFAOYSA-N 0.000 description 2
- YSBVQTLEWPKUSE-UHFFFAOYSA-N NN1CCC2=C(C=CC=C12)CC#N Chemical compound NN1CCC2=C(C=CC=C12)CC#N YSBVQTLEWPKUSE-UHFFFAOYSA-N 0.000 description 2
- PRYZTGJWHBGROI-UHFFFAOYSA-N O=C(NC1=C2C3=CC=CC=C3N=C2CC=C1)NN(CCC1=C2)C1=CC=C2N(CC1)CCC1C(F)(F)F Chemical compound O=C(NC1=C2C3=CC=CC=C3N=C2CC=C1)NN(CCC1=C2)C1=CC=C2N(CC1)CCC1C(F)(F)F PRYZTGJWHBGROI-UHFFFAOYSA-N 0.000 description 2
- HNEAUPWOLBVUEX-UHFFFAOYSA-N O=C(NC1=C2C3=CC=CC=C3N=C2CC=C1)NN1C2=CC=CC(N3CCCC3)=C2CC1 Chemical compound O=C(NC1=C2C3=CC=CC=C3N=C2CC=C1)NN1C2=CC=CC(N3CCCC3)=C2CC1 HNEAUPWOLBVUEX-UHFFFAOYSA-N 0.000 description 2
- 235000019502 Orange oil Nutrition 0.000 description 2
- 235000019483 Peanut oil Nutrition 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 238000010240 RT-PCR analysis Methods 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 150000004781 alginic acids Chemical class 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 2
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 2
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- 239000005557 antagonist Substances 0.000 description 2
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 2
- 125000005110 aryl thio group Chemical group 0.000 description 2
- 125000004104 aryloxy group Chemical group 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 125000000440 benzylamino group Chemical group [H]N(*)C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 229920002988 biodegradable polymer Polymers 0.000 description 2
- 239000004621 biodegradable polymer Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-M carbamimidate Chemical compound NC([NH-])=O XSQUKJJJFZCRTK-UHFFFAOYSA-M 0.000 description 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 2
- CVXBEEMKQHEXEN-UHFFFAOYSA-N carbaryl Chemical compound C1=CC=C2C(OC(=O)NC)=CC=CC2=C1 CVXBEEMKQHEXEN-UHFFFAOYSA-N 0.000 description 2
- 229960005286 carbaryl Drugs 0.000 description 2
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 229940110456 cocoa butter Drugs 0.000 description 2
- 235000019868 cocoa butter Nutrition 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 235000005687 corn oil Nutrition 0.000 description 2
- 239000002285 corn oil Substances 0.000 description 2
- 235000012343 cottonseed oil Nutrition 0.000 description 2
- 239000002385 cottonseed oil Substances 0.000 description 2
- RWGFKTVRMDUZSP-UHFFFAOYSA-N cumene Chemical compound CC(C)C1=CC=CC=C1 RWGFKTVRMDUZSP-UHFFFAOYSA-N 0.000 description 2
- 238000006264 debenzylation reaction Methods 0.000 description 2
- 150000005690 diesters Chemical class 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 2
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 2
- 229940093471 ethyl oleate Drugs 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000003701 inert diluent Substances 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 229940011051 isopropyl acetate Drugs 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 2
- 125000000468 ketone group Chemical group 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 239000008297 liquid dosage form Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- NALNAVBKNGSVOX-UHFFFAOYSA-N methyl 4-[[4-(2-methylpyrrolidin-1-yl)-2,3-dihydro-1h-inden-1-yl]carbamoylamino]indazole-1-carboxylate Chemical compound C1=CC=C2N(C(=O)OC)N=CC2=C1NC(=O)NC1CCC2=C1C=CC=C2N1CCCC1C NALNAVBKNGSVOX-UHFFFAOYSA-N 0.000 description 2
- AYTUKTYPOFBOMF-UHFFFAOYSA-N methyl 4-aminoindazole-1-carboxylate Chemical compound C1=CC=C2N(C(=O)OC)N=CC2=C1N AYTUKTYPOFBOMF-UHFFFAOYSA-N 0.000 description 2
- XOGIKWSCTIFLGT-UHFFFAOYSA-N methyl 9h-carbazole-1-carboxylate Chemical compound C12=CC=CC=C2NC2=C1C=CC=C2C(=O)OC XOGIKWSCTIFLGT-UHFFFAOYSA-N 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- SOFXDHKUELFSQW-UHFFFAOYSA-N methyl indazole-1-carboxylate Chemical compound C1=CC=C2N(C(=O)OC)N=CC2=C1 SOFXDHKUELFSQW-UHFFFAOYSA-N 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- HDZGCSFEDULWCS-UHFFFAOYSA-N monomethylhydrazine Chemical compound CNN HDZGCSFEDULWCS-UHFFFAOYSA-N 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- VBEGHXKAFSLLGE-UHFFFAOYSA-N n-phenylnitramide Chemical compound [O-][N+](=O)NC1=CC=CC=C1 VBEGHXKAFSLLGE-UHFFFAOYSA-N 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 230000000269 nucleophilic effect Effects 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000010502 orange oil Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 150000002923 oximes Chemical class 0.000 description 2
- 239000000312 peanut oil Substances 0.000 description 2
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 2
- XUWHAWMETYGRKB-UHFFFAOYSA-N piperidin-2-one Chemical compound O=C1CCCCN1 XUWHAWMETYGRKB-UHFFFAOYSA-N 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- IVRIRQXJSNCSPQ-UHFFFAOYSA-N propan-2-yl carbonochloridate Chemical compound CC(C)OC(Cl)=O IVRIRQXJSNCSPQ-UHFFFAOYSA-N 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 239000008159 sesame oil Substances 0.000 description 2
- 235000011803 sesame oil Nutrition 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical class [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
- 239000008247 solid mixture Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 125000004434 sulfur atom Chemical group 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- UCPYLLCMEDAXFR-UHFFFAOYSA-N triphosgene Chemical compound ClC(Cl)(Cl)OC(=O)OC(Cl)(Cl)Cl UCPYLLCMEDAXFR-UHFFFAOYSA-N 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 229940075420 xanthine Drugs 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- BGMIGJXEIMVBGD-UHFFFAOYSA-N (1-methoxy-2-methylpropan-2-yl)benzene Chemical compound COCC(C)(C)C1=CC=CC=C1 BGMIGJXEIMVBGD-UHFFFAOYSA-N 0.000 description 1
- OLTRFLJKPXPCCI-SSDOTTSWSA-N (2r)-2-(ethylamino)-4-methylpentanoic acid Chemical compound CCN[C@@H](C(O)=O)CC(C)C OLTRFLJKPXPCCI-SSDOTTSWSA-N 0.000 description 1
- UHEPSJJJMTWUCP-DHDYTCSHSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2s,3r,4r,5s,6r)-3-amino-4,5-dihydroxy-6-[(1r)-1-hydroxyethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;sulfuric acid Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H]([C@@H](C)O)O2)N)[C@@H](N)C[C@H]1N UHEPSJJJMTWUCP-DHDYTCSHSA-N 0.000 description 1
- LKRBJGQCGJSSSX-UHFFFAOYSA-N (3-bromophenyl)methyl acetate Chemical compound CC(=O)OCC1=CC=CC(Br)=C1 LKRBJGQCGJSSSX-UHFFFAOYSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 1
- FIARMZDBEGVMLV-UHFFFAOYSA-N 1,1,2,2,2-pentafluoroethanolate Chemical group [O-]C(F)(F)C(F)(F)F FIARMZDBEGVMLV-UHFFFAOYSA-N 0.000 description 1
- VZXTWGWHSMCWGA-UHFFFAOYSA-N 1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(N)=N1 VZXTWGWHSMCWGA-UHFFFAOYSA-N 0.000 description 1
- QDVBKXJMLILLLB-UHFFFAOYSA-N 1,4'-bipiperidine Chemical compound C1CCCCN1C1CCNCC1 QDVBKXJMLILLLB-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- RMVHAIQPCFLJPM-UHFFFAOYSA-N 1-(1H-indazol-4-yl)-3-[5-(trifluoromethyl)-2,3-dihydroindol-1-yl]urea Chemical compound N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=CC(=CC=C12)C(F)(F)F RMVHAIQPCFLJPM-UHFFFAOYSA-N 0.000 description 1
- YCAAQLHPLMLUQY-UHFFFAOYSA-N 1-(5,6-dimethoxy-2,3-dihydro-1h-inden-1-yl)-3-(1h-indazol-4-yl)urea Chemical compound C1=2C=C(OC)C(OC)=CC=2CCC1NC(=O)NC1=CC=CC2=C1C=NN2 YCAAQLHPLMLUQY-UHFFFAOYSA-N 0.000 description 1
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 1
- CJHYHNWJRPRTDB-UHFFFAOYSA-N 1-[4-(4-fluoropiperidin-1-yl)-2,3-dihydro-1h-inden-1-yl]-3-(1h-indazol-4-yl)urea Chemical compound C1CC(F)CCN1C1=CC=CC2=C1CCC2NC(=O)NC1=CC=CC2=C1C=NN2 CJHYHNWJRPRTDB-UHFFFAOYSA-N 0.000 description 1
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 1
- ITYCJCVRPBLODP-UHFFFAOYSA-N 1-bromo-2-(trifluoromethoxy)benzene Chemical compound FC(F)(F)OC1=CC=CC=C1Br ITYCJCVRPBLODP-UHFFFAOYSA-N 0.000 description 1
- RWXUNIMBRXGNEP-UHFFFAOYSA-N 1-bromo-2-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=CC=C1Br RWXUNIMBRXGNEP-UHFFFAOYSA-N 0.000 description 1
- 125000004972 1-butynyl group Chemical group [H]C([H])([H])C([H])([H])C#C* 0.000 description 1
- 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 description 1
- VPLXJIGDEIRJLV-UHFFFAOYSA-N 12,12-dimethyltridec-1-yne Chemical group CC(CCCCCCCCCC#C)(C)C VPLXJIGDEIRJLV-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- MGHNDJJPPOAIHK-UHFFFAOYSA-N 1H-inden-1-yl Chemical group C1=CC=C2[CH]C=CC2=C1 MGHNDJJPPOAIHK-UHFFFAOYSA-N 0.000 description 1
- IHWDSEPNZDYMNF-UHFFFAOYSA-N 1H-indol-2-amine Chemical compound C1=CC=C2NC(N)=CC2=C1 IHWDSEPNZDYMNF-UHFFFAOYSA-N 0.000 description 1
- 125000003562 2,2-dimethylpentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- WLFGGJFWKXTOGJ-UHFFFAOYSA-N 2,3-dihydroindol-1-amine Chemical compound C1=CC=C2N(N)CCC2=C1 WLFGGJFWKXTOGJ-UHFFFAOYSA-N 0.000 description 1
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 1
- 125000003660 2,3-dimethylpentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- HNVIQLPOGUDBSU-UHFFFAOYSA-N 2,6-dimethylmorpholine Chemical compound CC1CNCC(C)O1 HNVIQLPOGUDBSU-UHFFFAOYSA-N 0.000 description 1
- BVCOJESIQPNOIF-UHFFFAOYSA-N 2-(2-bromophenyl)acetonitrile Chemical compound BrC1=CC=CC=C1CC#N BVCOJESIQPNOIF-UHFFFAOYSA-N 0.000 description 1
- FPZWZCWUIYYYBU-UHFFFAOYSA-N 2-(2-ethoxyethoxy)ethyl acetate Chemical group CCOCCOCCOC(C)=O FPZWZCWUIYYYBU-UHFFFAOYSA-N 0.000 description 1
- IAJLEXJOQGSTAW-UHFFFAOYSA-N 2-(3-bromophenyl)-2-methylpropan-1-ol Chemical compound OCC(C)(C)C1=CC=CC(Br)=C1 IAJLEXJOQGSTAW-UHFFFAOYSA-N 0.000 description 1
- KYNNBXCGXUOREX-UHFFFAOYSA-N 2-(3-bromophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1 KYNNBXCGXUOREX-UHFFFAOYSA-N 0.000 description 1
- UUZYFBXKWIQKTF-UHFFFAOYSA-N 2-(3-bromophenyl)acetonitrile Chemical compound BrC1=CC=CC(CC#N)=C1 UUZYFBXKWIQKTF-UHFFFAOYSA-N 0.000 description 1
- GNAAMZAIXVECEW-UHFFFAOYSA-N 2-(3-bromophenyl)ethyl acetate Chemical compound CC(=O)OCCC1=CC=CC(Br)=C1 GNAAMZAIXVECEW-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- AWYXNIWXOXKRDQ-UHFFFAOYSA-N 2-butyl-2,3-dihydroinden-1-one Chemical compound C1=CC=C2C(=O)C(CCCC)CC2=C1 AWYXNIWXOXKRDQ-UHFFFAOYSA-N 0.000 description 1
- 125000000143 2-carboxyethyl group Chemical group [H]OC(=O)C([H])([H])C([H])([H])* 0.000 description 1
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 description 1
- 125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- 125000006022 2-methyl-2-propenyl group Chemical group 0.000 description 1
- VNJOEUSYAMPBAK-UHFFFAOYSA-N 2-methylbenzenesulfonic acid;hydrate Chemical compound O.CC1=CC=CC=C1S(O)(=O)=O VNJOEUSYAMPBAK-UHFFFAOYSA-N 0.000 description 1
- RJOJSUQEQYDWTE-UHFFFAOYSA-N 2-methylpropyl 4-aminoindazole-1-carboxylate Chemical compound C1=CC=C2N(C(=O)OCC(C)C)N=CC2=C1N RJOJSUQEQYDWTE-UHFFFAOYSA-N 0.000 description 1
- RGKJYHNFHRPBFH-UHFFFAOYSA-N 2-methylpropyl 4-nitroindazole-1-carboxylate Chemical compound C1=CC=C2N(C(=O)OCC(C)C)N=CC2=C1[N+]([O-])=O RGKJYHNFHRPBFH-UHFFFAOYSA-N 0.000 description 1
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 1
- RGHPCLZJAFCTIK-UHFFFAOYSA-N 2-methylpyrrolidine Chemical compound CC1CCCN1 RGHPCLZJAFCTIK-UHFFFAOYSA-N 0.000 description 1
- 229940080296 2-naphthalenesulfonate Drugs 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- UOGQPXQDNUHUIB-UHFFFAOYSA-N 3,3-difluoropiperidine Chemical compound FC1(F)CCCNC1 UOGQPXQDNUHUIB-UHFFFAOYSA-N 0.000 description 1
- UOZIYCHJMUNLIG-UHFFFAOYSA-N 3-(3,4-difluorophenyl)propanoic acid Chemical compound OC(=O)CCC1=CC=C(F)C(F)=C1 UOZIYCHJMUNLIG-UHFFFAOYSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- 125000000474 3-butynyl group Chemical group [H]C#CC([H])([H])C([H])([H])* 0.000 description 1
- LKWSQOOHFOIWDG-UHFFFAOYSA-N 3-chloro-1-(4-propan-2-ylphenyl)propan-1-one Chemical compound CC(C)C1=CC=C(C(=O)CCCl)C=C1 LKWSQOOHFOIWDG-UHFFFAOYSA-N 0.000 description 1
- YUKQZLBLVRAJSW-UHFFFAOYSA-N 3-fluoropiperidine Chemical compound FC1CCCNC1 YUKQZLBLVRAJSW-UHFFFAOYSA-N 0.000 description 1
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 1
- 125000003469 3-methylhexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- MJOUJKDTBGXKIU-UHFFFAOYSA-N 4,4-difluoropiperidine Chemical compound FC1(F)CCNCC1 MJOUJKDTBGXKIU-UHFFFAOYSA-N 0.000 description 1
- XQODIRIVQXQUFN-UHFFFAOYSA-N 4,5-dimethoxy-2,3-dihydroinden-1-one Chemical compound COC1=CC=C2C(=O)CCC2=C1OC XQODIRIVQXQUFN-UHFFFAOYSA-N 0.000 description 1
- ULSFTTGVCAJHNL-UHFFFAOYSA-N 4-(trifluoromethoxy)-2,3-dihydroinden-1-one Chemical compound FC(F)(F)OC1=CC=CC2=C1CCC2=O ULSFTTGVCAJHNL-UHFFFAOYSA-N 0.000 description 1
- RDRQUUWCJTYHCT-UHFFFAOYSA-N 4-(trifluoromethyl)piperidine Chemical compound FC(F)(F)C1CCNCC1 RDRQUUWCJTYHCT-UHFFFAOYSA-N 0.000 description 1
- MYCZDIIPHIGLCH-UHFFFAOYSA-N 4-chloro-2,3-dihydroinden-1-one Chemical compound ClC1=CC=CC2=C1CCC2=O MYCZDIIPHIGLCH-UHFFFAOYSA-N 0.000 description 1
- QBLLOOKBLTTXHB-UHFFFAOYSA-N 4-fluoropiperidine Chemical compound FC1CCNCC1 QBLLOOKBLTTXHB-UHFFFAOYSA-N 0.000 description 1
- MQVWPHWBMNOCAT-UHFFFAOYSA-N 4-nitro-9h-carbazole Chemical compound N1C2=CC=CC=C2C2=C1C=CC=C2[N+](=O)[O-] MQVWPHWBMNOCAT-UHFFFAOYSA-N 0.000 description 1
- UTBULQCHEUWJNV-UHFFFAOYSA-N 4-phenylpiperidine Chemical compound C1CNCCC1C1=CC=CC=C1 UTBULQCHEUWJNV-UHFFFAOYSA-N 0.000 description 1
- ZKMVSLYDIUDEGL-UHFFFAOYSA-N 4-pyridin-2-yl-2,3-dihydroinden-1-one Chemical compound O=C1CCC2=C1C=CC=C2C1=CC=CC=N1 ZKMVSLYDIUDEGL-UHFFFAOYSA-N 0.000 description 1
- OSJRTWXVMCRBKZ-UHFFFAOYSA-N 5,6-difluoro-2,3-dihydroinden-1-one Chemical compound C1=C(F)C(F)=CC2=C1C(=O)CC2 OSJRTWXVMCRBKZ-UHFFFAOYSA-N 0.000 description 1
- IHMQOBPGHZFGLC-UHFFFAOYSA-N 5,6-dimethoxy-2,3-dihydroinden-1-one Chemical compound C1=C(OC)C(OC)=CC2=C1C(=O)CC2 IHMQOBPGHZFGLC-UHFFFAOYSA-N 0.000 description 1
- KRDHNSGNGVNBQQ-UHFFFAOYSA-N 5-(4-methylpiperidin-1-yl)-2,3-dihydro-1h-inden-1-amine Chemical compound C1CC(C)CCN1C1=CC=C(C(N)CC2)C2=C1 KRDHNSGNGVNBQQ-UHFFFAOYSA-N 0.000 description 1
- WPPJJNMBOREUIZ-UHFFFAOYSA-N 5-(azepan-1-yl)-2,3-dihydro-1h-inden-1-amine Chemical compound C=1C=C2C(N)CCC2=CC=1N1CCCCCC1 WPPJJNMBOREUIZ-UHFFFAOYSA-N 0.000 description 1
- OCKGFTQIICXDQW-ZEQRLZLVSA-N 5-[(1r)-1-hydroxy-2-[4-[(2r)-2-hydroxy-2-(4-methyl-1-oxo-3h-2-benzofuran-5-yl)ethyl]piperazin-1-yl]ethyl]-4-methyl-3h-2-benzofuran-1-one Chemical compound C1=C2C(=O)OCC2=C(C)C([C@@H](O)CN2CCN(CC2)C[C@H](O)C2=CC=C3C(=O)OCC3=C2C)=C1 OCKGFTQIICXDQW-ZEQRLZLVSA-N 0.000 description 1
- KSONICAHAPRCMV-UHFFFAOYSA-N 5-bromo-2,3-dihydroinden-1-one Chemical compound BrC1=CC=C2C(=O)CCC2=C1 KSONICAHAPRCMV-UHFFFAOYSA-N 0.000 description 1
- RZAKZBSQPHXBDB-UHFFFAOYSA-N 5-bromo-2,3-dihydroindol-1-amine Chemical compound BrC1=CC=C2N(N)CCC2=C1 RZAKZBSQPHXBDB-UHFFFAOYSA-N 0.000 description 1
- CCNOGOGUHOMLMI-UHFFFAOYSA-N 5-chloro-2,3-dihydro-1h-inden-1-amine Chemical compound ClC1=CC=C2C(N)CCC2=C1 CCNOGOGUHOMLMI-UHFFFAOYSA-N 0.000 description 1
- MEDSHTHCZIOVPU-UHFFFAOYSA-N 5-chloro-2,3-dihydroinden-1-one Chemical compound ClC1=CC=C2C(=O)CCC2=C1 MEDSHTHCZIOVPU-UHFFFAOYSA-N 0.000 description 1
- POTIEZMRLKEJOZ-UHFFFAOYSA-N 5-fluoro-2,3-dihydro-1h-inden-1-amine Chemical compound FC1=CC=C2C(N)CCC2=C1 POTIEZMRLKEJOZ-UHFFFAOYSA-N 0.000 description 1
- DOVJRLZHEDUVMB-UHFFFAOYSA-N 5-fluoro-2,3-dihydroindol-1-amine Chemical compound FC1=CC=C2N(N)CCC2=C1 DOVJRLZHEDUVMB-UHFFFAOYSA-N 0.000 description 1
- 125000006043 5-hexenyl group Chemical group 0.000 description 1
- CVHZEQDQDMDUHT-UHFFFAOYSA-N 5-isocyanato-3-methylisoquinoline Chemical compound C1=CC=C2C=NC(C)=CC2=C1N=C=O CVHZEQDQDMDUHT-UHFFFAOYSA-N 0.000 description 1
- BIYHMCGHGLLTIN-UHFFFAOYSA-N 5-methoxy-2,3-dihydro-1h-inden-1-amine Chemical compound COC1=CC=C2C(N)CCC2=C1 BIYHMCGHGLLTIN-UHFFFAOYSA-N 0.000 description 1
- QOPRWBRNMPANKN-UHFFFAOYSA-N 5-methoxy-2,3-dihydroinden-1-one Chemical compound COC1=CC=C2C(=O)CCC2=C1 QOPRWBRNMPANKN-UHFFFAOYSA-N 0.000 description 1
- FVGKWRLEJUDITN-UHFFFAOYSA-N 5-methoxy-2,3-dihydroindol-1-amine Chemical compound COC1=CC=C2N(N)CCC2=C1 FVGKWRLEJUDITN-UHFFFAOYSA-N 0.000 description 1
- VSHYKOHIJXNBSA-UHFFFAOYSA-N 5-tert-butyl-2,2-difluoro-1,3-dihydroinden-1-amine Chemical compound CC(C)(C)C1=CC=C2C(N)C(F)(F)CC2=C1 VSHYKOHIJXNBSA-UHFFFAOYSA-N 0.000 description 1
- PKYLKECKEABYMN-UHFFFAOYSA-N 5-tert-butyl-2,2-difluoro-3a,4-dihydro-3H-indol-1-amine Chemical compound C(C)(C)(C)C=1CC2CC(N(C2=CC1)N)(F)F PKYLKECKEABYMN-UHFFFAOYSA-N 0.000 description 1
- PXHBNYQATBUYRL-UHFFFAOYSA-N 5-tert-butyl-n-methoxy-2,3-dihydroinden-1-imine Chemical compound CC(C)(C)C1=CC=C2C(=NOC)CCC2=C1 PXHBNYQATBUYRL-UHFFFAOYSA-N 0.000 description 1
- YUQIKEGBLKSWJL-UHFFFAOYSA-N 6-fluoro-5-piperidin-1-yl-2,3-dihydroinden-1-one Chemical compound FC1=CC=2C(=O)CCC=2C=C1N1CCCCC1 YUQIKEGBLKSWJL-UHFFFAOYSA-N 0.000 description 1
- VYGIPIBKCOYHFK-UHFFFAOYSA-N 6-methoxy-2,3-dihydro-1h-inden-1-amine Chemical compound COC1=CC=C2CCC(N)C2=C1 VYGIPIBKCOYHFK-UHFFFAOYSA-N 0.000 description 1
- UJGDLLGKMWVCPT-UHFFFAOYSA-N 6-methoxy-2,3-dihydroinden-1-one Chemical compound COC1=CC=C2CCC(=O)C2=C1 UJGDLLGKMWVCPT-UHFFFAOYSA-N 0.000 description 1
- URNGGHZQVMVSGS-UHFFFAOYSA-N 6-methoxy-2,3-dihydroindol-1-amine Chemical compound COC1=CC=C2CCN(N)C2=C1 URNGGHZQVMVSGS-UHFFFAOYSA-N 0.000 description 1
- FMQGLSSKBZCURE-UHFFFAOYSA-N 6-methyl-2,3-dihydro-1h-inden-1-amine Chemical compound CC1=CC=C2CCC(N)C2=C1 FMQGLSSKBZCURE-UHFFFAOYSA-N 0.000 description 1
- LXMAZZDOCQRHRI-UHFFFAOYSA-N 6-methyl-2,3-dihydroindol-1-amine Chemical compound CC1=CC=C2CCN(N)C2=C1 LXMAZZDOCQRHRI-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- DGGKXQQCVPAUEA-UHFFFAOYSA-N 8-azabicyclo[3.2.1]octane Chemical compound C1CCC2CCC1N2 DGGKXQQCVPAUEA-UHFFFAOYSA-N 0.000 description 1
- JRLTTZUODKEYDH-UHFFFAOYSA-N 8-methylquinoline Chemical group C1=CN=C2C(C)=CC=CC2=C1 JRLTTZUODKEYDH-UHFFFAOYSA-N 0.000 description 1
- NHSSUEOHJNWVLL-UHFFFAOYSA-N 9h-carbazole-1-carbohydrazide Chemical compound C12=CC=CC=C2NC2=C1C=CC=C2C(=O)NN NHSSUEOHJNWVLL-UHFFFAOYSA-N 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- XGGHMLBMOUDXER-UHFFFAOYSA-N BrC1=C2CCN(C2=CC=C1)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O Chemical compound BrC1=C2CCN(C2=CC=C1)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O XGGHMLBMOUDXER-UHFFFAOYSA-N 0.000 description 1
- QRLHYZJCGWVIGY-UHFFFAOYSA-N BrC1=CC(=CC=C1)C(C(CC(CCCCCCCC)C(C)(C)C)(C)C)(C)C Chemical compound BrC1=CC(=CC=C1)C(C(CC(CCCCCCCC)C(C)(C)C)(C)C)(C)C QRLHYZJCGWVIGY-UHFFFAOYSA-N 0.000 description 1
- MMWFPYAEHIUTMF-UHFFFAOYSA-N C#C.CC(CCCCCCCCC)(C)C Chemical compound C#C.CC(CCCCCCCCC)(C)C MMWFPYAEHIUTMF-UHFFFAOYSA-N 0.000 description 1
- HKNKXEBRQIYFDN-UHFFFAOYSA-N C(C(C)C)OC(=O)C1C=CC(=C2C3=CC=CC=C3N=C12)[N+](=O)[O-] Chemical compound C(C(C)C)OC(=O)C1C=CC(=C2C3=CC=CC=C3N=C12)[N+](=O)[O-] HKNKXEBRQIYFDN-UHFFFAOYSA-N 0.000 description 1
- GRHWECPXCGAHFN-UHFFFAOYSA-N C(C)(C)(C)C=1C(=C2CCNC2=CC1)NC(=O)NC1=C2C=NNC2=CC=C1 Chemical compound C(C)(C)(C)C=1C(=C2CCNC2=CC1)NC(=O)NC1=C2C=NNC2=CC=C1 GRHWECPXCGAHFN-UHFFFAOYSA-N 0.000 description 1
- KUSXTRLTNFMADE-UHFFFAOYSA-N C(C)(C)(C)C=1C=C2CC(N(C2=CC1)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O)F Chemical compound C(C)(C)(C)C=1C=C2CC(N(C2=CC1)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O)F KUSXTRLTNFMADE-UHFFFAOYSA-N 0.000 description 1
- XKCRJTYUDDNRRM-UHFFFAOYSA-N C(C)(C)(C)C=1C=C2CC(NC2=CC1)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O Chemical compound C(C)(C)(C)C=1C=C2CC(NC2=CC1)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O XKCRJTYUDDNRRM-UHFFFAOYSA-N 0.000 description 1
- VHZCRSMWMOGPLS-OAHLLOKOSA-N C(C)(C)(C)C=1C=C2CCN(C2=CC1)N[C@H](C)C1=CC=CC=C1 Chemical compound C(C)(C)(C)C=1C=C2CCN(C2=CC1)N[C@H](C)C1=CC=CC=C1 VHZCRSMWMOGPLS-OAHLLOKOSA-N 0.000 description 1
- FHEJYYKSZTZZGA-UHFFFAOYSA-N C(C)(C)C=1C=C2CCN(C2=CC1)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O Chemical compound C(C)(C)C=1C=C2CCN(C2=CC1)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O FHEJYYKSZTZZGA-UHFFFAOYSA-N 0.000 description 1
- XVTDJLKSKQHFBD-UHFFFAOYSA-N C(C)(C)OC(=O)C1C=CC(=C2C3=CC=CC=C3N=C12)[N+](=O)[O-] Chemical compound C(C)(C)OC(=O)C1C=CC(=C2C3=CC=CC=C3N=C12)[N+](=O)[O-] XVTDJLKSKQHFBD-UHFFFAOYSA-N 0.000 description 1
- VMWAHPAYCHLLKN-UHFFFAOYSA-N C(C)N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=CC(=C(C=C12)OC)OC Chemical compound C(C)N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=CC(=C(C=C12)OC)OC VMWAHPAYCHLLKN-UHFFFAOYSA-N 0.000 description 1
- OGOZCOVRXWYBGL-UHFFFAOYSA-N C(N)(O)=O.C(=O)(O)C=1C=CC=2NC3=CC=CC=C3C2C1 Chemical class C(N)(O)=O.C(=O)(O)C=1C=CC=2NC3=CC=CC=C3C2C1 OGOZCOVRXWYBGL-UHFFFAOYSA-N 0.000 description 1
- PWXUVOVGJPPWED-UHFFFAOYSA-N C(N)(OC=1OC=C(N1)[N+](=O)[O-])=O Chemical compound C(N)(OC=1OC=C(N1)[N+](=O)[O-])=O PWXUVOVGJPPWED-UHFFFAOYSA-N 0.000 description 1
- CETUBGAXGPCPDQ-UHFFFAOYSA-N C12(NCC(CC1)C2)C21CCC(CC2)C1 Chemical compound C12(NCC(CC1)C2)C21CCC(CC2)C1 CETUBGAXGPCPDQ-UHFFFAOYSA-N 0.000 description 1
- HLIASRPEOARRJV-UHFFFAOYSA-N C12CCCC(CC1)N2C2=C1CCN(C1=CC=C2)N Chemical compound C12CCCC(CC1)N2C2=C1CCN(C1=CC=C2)N HLIASRPEOARRJV-UHFFFAOYSA-N 0.000 description 1
- OLQFCYSAMBTLKX-UHFFFAOYSA-N C12N(CC(CC1)C2)C2=C1CCN(C1=CC=C2)N Chemical compound C12N(CC(CC1)C2)C2=C1CCN(C1=CC=C2)N OLQFCYSAMBTLKX-UHFFFAOYSA-N 0.000 description 1
- IPWVXRKEAHVDTM-UHFFFAOYSA-N C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=C(C=CC=C12)N1CC2CCCCC2CC1 Chemical compound C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=C(C=CC=C12)N1CC2CCCCC2CC1 IPWVXRKEAHVDTM-UHFFFAOYSA-N 0.000 description 1
- MBPQKRSUWKRVBO-UHFFFAOYSA-N C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=CC(=CC=C12)N1CCCCC1 Chemical compound C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=CC(=CC=C12)N1CCCCC1 MBPQKRSUWKRVBO-UHFFFAOYSA-N 0.000 description 1
- YYAGCMKEAOVJBO-UHFFFAOYSA-N C1N(CCC2CCCCC12)C1=C2CCN(C2=CC=C1)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O Chemical compound C1N(CCC2CCCCC12)C1=C2CCN(C2=CC=C1)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O YYAGCMKEAOVJBO-UHFFFAOYSA-N 0.000 description 1
- JUHYOSANUDGSEY-DZGCQCFKSA-N C1N(CC[C@@H]2CCCC[C@H]12)C=1C=C2CCN(C2=CC1)N Chemical compound C1N(CC[C@@H]2CCCC[C@H]12)C=1C=C2CCN(C2=CC1)N JUHYOSANUDGSEY-DZGCQCFKSA-N 0.000 description 1
- VBHFLKDFSKPBPL-UHFFFAOYSA-N CC1=C2CCN(C2=CC=C1)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O Chemical compound CC1=C2CCN(C2=CC=C1)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O VBHFLKDFSKPBPL-UHFFFAOYSA-N 0.000 description 1
- ICUGOCZTXDWODX-UHFFFAOYSA-N CC1CN(CC(O1)C)C1=C2CCN(C2=CC=C1)N Chemical compound CC1CN(CC(O1)C)C1=C2CCN(C2=CC=C1)N ICUGOCZTXDWODX-UHFFFAOYSA-N 0.000 description 1
- BEPXFPJPKDFOLH-UHFFFAOYSA-N CC1CN(CCC1)C=1C=C2CCN(C2=CC1)N Chemical compound CC1CN(CCC1)C=1C=C2CCN(C2=CC1)N BEPXFPJPKDFOLH-UHFFFAOYSA-N 0.000 description 1
- DKTVDHSMNVOUGD-UHFFFAOYSA-N CC1N(CCCC1)C1=C2CCN(C2=CC=C1)N Chemical compound CC1N(CCCC1)C1=C2CCN(C2=CC=C1)N DKTVDHSMNVOUGD-UHFFFAOYSA-N 0.000 description 1
- XWMSUMIKHQLKDB-UHFFFAOYSA-N COC(=O)C1=CC=C(C=2C3=CC=CC=C3NC12)N Chemical compound COC(=O)C1=CC=C(C=2C3=CC=CC=C3NC12)N XWMSUMIKHQLKDB-UHFFFAOYSA-N 0.000 description 1
- DXBRMLUXIRNCHP-UHFFFAOYSA-N COC(=O)C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=CC(=CC=C12)C(F)(F)F Chemical compound COC(=O)C1C=CC(=C2C3=CC=CC=C3N=C12)NC(=O)NN1CCC2=CC(=CC=C12)C(F)(F)F DXBRMLUXIRNCHP-UHFFFAOYSA-N 0.000 description 1
- LXFRCKHRFFMORR-UHFFFAOYSA-N COC(=O)N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=CC(=CC=C12)C Chemical compound COC(=O)N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=CC(=CC=C12)C LXFRCKHRFFMORR-UHFFFAOYSA-N 0.000 description 1
- KNNXXEWYRNLZOO-UHFFFAOYSA-N COC(=O)N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=CC=CC(=C12)C Chemical compound COC(=O)N1N=CC2=C(C=CC=C12)NC(=O)NN1CCC2=CC=CC(=C12)C KNNXXEWYRNLZOO-UHFFFAOYSA-N 0.000 description 1
- SXUAEHWSGBEWIA-UHFFFAOYSA-N COC1=C2CCN(C2=CC=C1OC)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O Chemical compound COC1=C2CCN(C2=CC=C1OC)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O SXUAEHWSGBEWIA-UHFFFAOYSA-N 0.000 description 1
- GCPGOHUTXNCVDJ-UHFFFAOYSA-N COC=1C=C2CCN(C2=CC1)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O Chemical compound COC=1C=C2CCN(C2=CC1)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O GCPGOHUTXNCVDJ-UHFFFAOYSA-N 0.000 description 1
- MNMFGLBBPGXBJG-UHFFFAOYSA-N COC=1C=C2CCN(C2=CC1OC)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O Chemical compound COC=1C=C2CCN(C2=CC1OC)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O MNMFGLBBPGXBJG-UHFFFAOYSA-N 0.000 description 1
- WSEMVZMRBJNECB-UHFFFAOYSA-N COCC(C)(C)C=1C=C2CCN(C2=CC1)N Chemical compound COCC(C)(C)C=1C=C2CCN(C2=CC1)N WSEMVZMRBJNECB-UHFFFAOYSA-N 0.000 description 1
- 108090000932 Calcitonin Gene-Related Peptide Proteins 0.000 description 1
- 102100025588 Calcitonin gene-related peptide 1 Human genes 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- YOGKMPSBDCLVLG-UHFFFAOYSA-N ClC1=C2CCN(C2=CC=C1)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O Chemical compound ClC1=C2CCN(C2=CC=C1)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O YOGKMPSBDCLVLG-UHFFFAOYSA-N 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- IKYCZSUNGFRBJS-UHFFFAOYSA-N Euphorbia factor RL9 = U(1) = Resiniferatoxin Natural products COC1=CC(O)=CC(CC(=O)OCC=2CC3(O)C(=O)C(C)=CC3C34C(C)CC5(OC(O4)(CC=4C=CC=CC=4)OC5C3C=2)C(C)=C)=C1 IKYCZSUNGFRBJS-UHFFFAOYSA-N 0.000 description 1
- AUQABIAMYZYRKQ-UHFFFAOYSA-N FC(C=1C=C2CCN(C2=CC1)N)(F)F Chemical compound FC(C=1C=C2CCN(C2=CC1)N)(F)F AUQABIAMYZYRKQ-UHFFFAOYSA-N 0.000 description 1
- VIFLASLCNRVPHL-UHFFFAOYSA-N FC1CCN(CC1)C1=C2CCN(C2=CC=C1)N Chemical compound FC1CCN(CC1)C1=C2CCN(C2=CC=C1)N VIFLASLCNRVPHL-UHFFFAOYSA-N 0.000 description 1
- OUVXYXNWSVIOSJ-UHFFFAOYSA-N Fluo-4 Chemical compound CC1=CC=C(N(CC(O)=O)CC(O)=O)C(OCCOC=2C(=CC=C(C=2)C2=C3C=C(F)C(=O)C=C3OC3=CC(O)=C(F)C=C32)N(CC(O)=O)CC(O)=O)=C1 OUVXYXNWSVIOSJ-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 1
- 239000004705 High-molecular-weight polyethylene Substances 0.000 description 1
- 101000666856 Homo sapiens Vasoactive intestinal polypeptide receptor 1 Proteins 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- GRRNUXAQVGOGFE-UHFFFAOYSA-N Hygromycin-B Natural products OC1C(NC)CC(N)C(O)C1OC1C2OC3(C(C(O)C(O)C(C(N)CO)O3)O)OC2C(O)C(CO)O1 GRRNUXAQVGOGFE-UHFFFAOYSA-N 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- 108090000862 Ion Channels Proteins 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 229910010082 LiAlH Inorganic materials 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- GMPKIPWJBDOURN-UHFFFAOYSA-N Methoxyamine Chemical compound CON GMPKIPWJBDOURN-UHFFFAOYSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- KQHIFHGTTUOWMD-UHFFFAOYSA-N N-(1-methoxy-2-methylpropan-2-yl)-2,3-dihydro-1H-inden-1-amine Chemical compound COCC(C)(C)NC1CCC2=CC=CC=C12 KQHIFHGTTUOWMD-UHFFFAOYSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 1
- IRCWXSJAILZNKZ-UHFFFAOYSA-N N1(CCCC1)C1=C2CCN(C2=CC=C1)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O Chemical compound N1(CCCC1)C1=C2CCN(C2=CC=C1)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O IRCWXSJAILZNKZ-UHFFFAOYSA-N 0.000 description 1
- YXLDWSVTTNUDCX-UHFFFAOYSA-N N1(CCCCC1)C1=C2CCN(C2=CC=C1)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O Chemical compound N1(CCCCC1)C1=C2CCN(C2=CC=C1)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O YXLDWSVTTNUDCX-UHFFFAOYSA-N 0.000 description 1
- WKFAAGWNKWVJQF-UHFFFAOYSA-N N1(CCCCC1)C1CCN(CC1)C=1C=C2CCN(C2=CC1)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O Chemical compound N1(CCCCC1)C1CCN(CC1)C=1C=C2CCN(C2=CC1)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O WKFAAGWNKWVJQF-UHFFFAOYSA-N 0.000 description 1
- ZPAYKMRUGQXHCJ-UHFFFAOYSA-N N1(CCCCCC1)C=1C=C2CCN(C2=CC1)N Chemical compound N1(CCCCCC1)C=1C=C2CCN(C2=CC1)N ZPAYKMRUGQXHCJ-UHFFFAOYSA-N 0.000 description 1
- YXIRIQUPVXSZSA-UHFFFAOYSA-N N1(CCCCCC1)C=1C=C2CCN(C2=CC1)NC(=O)NC1=C2C=NNC2=CC=C1 Chemical compound N1(CCCCCC1)C=1C=C2CCN(C2=CC1)NC(=O)NC1=C2C=NNC2=CC=C1 YXIRIQUPVXSZSA-UHFFFAOYSA-N 0.000 description 1
- QCJZRPPGNXTXRD-UHFFFAOYSA-N N1(CCOCC1)C1=C2CCN(C2=CC=C1)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O Chemical compound N1(CCOCC1)C1=C2CCN(C2=CC=C1)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O QCJZRPPGNXTXRD-UHFFFAOYSA-N 0.000 description 1
- VDNXGUIEYFFEQB-UHFFFAOYSA-N N1=C(C=CC=C1)C1=C2CCN(C2=CC=C1)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O Chemical compound N1=C(C=CC=C1)C1=C2CCN(C2=CC=C1)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O VDNXGUIEYFFEQB-UHFFFAOYSA-N 0.000 description 1
- ZYYSDSGMJKGWQC-UHFFFAOYSA-N N1=CC(=CC=C1)C1=C2CCN(C2=CC=C1)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O Chemical compound N1=CC(=CC=C1)C1=C2CCN(C2=CC=C1)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O ZYYSDSGMJKGWQC-UHFFFAOYSA-N 0.000 description 1
- TXMILVMWACJVLL-UHFFFAOYSA-N N1=CC=C(C=C1)C1=C2CCN(C2=CC=C1)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O Chemical compound N1=CC=C(C=C1)C1=C2CCN(C2=CC=C1)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O TXMILVMWACJVLL-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- SUHOOTKUPISOBE-UHFFFAOYSA-N O-phosphoethanolamine Chemical compound NCCOP(O)(O)=O SUHOOTKUPISOBE-UHFFFAOYSA-N 0.000 description 1
- YGBFAKSRWKLXDP-UHFFFAOYSA-N O=C1ONO1.N.N Chemical compound O=C1ONO1.N.N YGBFAKSRWKLXDP-UHFFFAOYSA-N 0.000 description 1
- CUWWUJYORJWUFL-UHFFFAOYSA-N OCC(C)(C)C=1C=C2CCN(C2=CC1)NC(=O)NC1=C2C=NNC2=CC=C1 Chemical compound OCC(C)(C)C=1C=C2CCN(C2=CC1)NC(=O)NC1=C2C=NNC2=CC=C1 CUWWUJYORJWUFL-UHFFFAOYSA-N 0.000 description 1
- CYTYCFOTNPOANT-UHFFFAOYSA-N Perchloroethylene Chemical compound ClC(Cl)=C(Cl)Cl CYTYCFOTNPOANT-UHFFFAOYSA-N 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920002732 Polyanhydride Polymers 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 229920001710 Polyorthoester Polymers 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- SSZBUIDZHHWXNJ-UHFFFAOYSA-N Stearinsaeure-hexadecylester Natural products CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC SSZBUIDZHHWXNJ-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- 102100038388 Vasoactive intestinal polypeptide receptor 1 Human genes 0.000 description 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 description 1
- RKBZIPDGPYQJGX-UHFFFAOYSA-N [N+](#[C-])C(CCCCC1=NC=CC2=CC=CC=C12)CCCCC Chemical compound [N+](#[C-])C(CCCCC1=NC=CC2=CC=CC=C12)CCCCC RKBZIPDGPYQJGX-UHFFFAOYSA-N 0.000 description 1
- LDCRIMRJMXCMBF-UHFFFAOYSA-N [N+](#[C-])CC1=C2C=C(N=CC2=CC=C1)C Chemical compound [N+](#[C-])CC1=C2C=C(N=CC2=CC=C1)C LDCRIMRJMXCMBF-UHFFFAOYSA-N 0.000 description 1
- QSVNQZRNGCBEGZ-UHFFFAOYSA-N [N+](#[C-])NNC1=C2C=CN=CC2=CC=C1 Chemical compound [N+](#[C-])NNC1=C2C=CN=CC2=CC=C1 QSVNQZRNGCBEGZ-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000003815 abdominal wall Anatomy 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000036982 action potential Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 125000005138 alkoxysulfonyl group Chemical group 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 150000003868 ammonium compounds Chemical class 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 239000012223 aqueous fraction Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 125000005098 aryl alkoxy carbonyl group Chemical group 0.000 description 1
- 210000001130 astrocyte Anatomy 0.000 description 1
- 125000003828 azulenyl group Chemical group 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- MUALRAIOVNYAIW-UHFFFAOYSA-N binap Chemical compound C1=CC=CC=C1P(C=1C(=C2C=CC=CC2=CC=1)C=1C2=CC=CC=C2C=CC=1P(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 MUALRAIOVNYAIW-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000036983 biotransformation Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- NRDQFWXVTPZZAZ-UHFFFAOYSA-N butyl carbonochloridate Chemical compound CCCCOC(Cl)=O NRDQFWXVTPZZAZ-UHFFFAOYSA-N 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical compound C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 description 1
- DRCMAZOSEIMCHM-UHFFFAOYSA-N capsazepine Chemical compound C1C=2C=C(O)C(O)=CC=2CCCN1C(=S)NCCC1=CC=C(Cl)C=C1 DRCMAZOSEIMCHM-UHFFFAOYSA-N 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- JOYKCMAPFCSKNO-UHFFFAOYSA-N chloro benzenesulfonate Chemical compound ClOS(=O)(=O)C1=CC=CC=C1 JOYKCMAPFCSKNO-UHFFFAOYSA-N 0.000 description 1
- FZFAMSAMCHXGEF-UHFFFAOYSA-N chloro formate Chemical compound ClOC=O FZFAMSAMCHXGEF-UHFFFAOYSA-N 0.000 description 1
- 229960004926 chlorobutanol Drugs 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 238000007282 cyclocarbonylation reaction Methods 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000586 desensitisation Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 150000001983 dialkylethers Chemical class 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- YNHIGQDRGKUECZ-UHFFFAOYSA-N dichloropalladium;triphenylphosphanium Chemical compound Cl[Pd]Cl.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-N 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- WYACBZDAHNBPPB-UHFFFAOYSA-N diethyl oxalate Chemical compound CCOC(=O)C(=O)OCC WYACBZDAHNBPPB-UHFFFAOYSA-N 0.000 description 1
- 125000005046 dihydronaphthyl group Chemical group 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 239000002702 enteric coating Substances 0.000 description 1
- 238000009505 enteric coating Methods 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 1
- 229940093499 ethyl acetate Drugs 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 1
- 125000006125 ethylsulfonyl group Chemical group 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000003885 eye ointment Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000012632 fluorescent imaging Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 125000003707 hexyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 210000000548 hind-foot Anatomy 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- GRRNUXAQVGOGFE-NZSRVPFOSA-N hygromycin B Chemical compound O[C@@H]1[C@@H](NC)C[C@@H](N)[C@H](O)[C@H]1O[C@H]1[C@H]2O[C@@]3([C@@H]([C@@H](O)[C@@H](O)[C@@H](C(N)CO)O3)O)O[C@H]2[C@@H](O)[C@@H](CO)O1 GRRNUXAQVGOGFE-NZSRVPFOSA-N 0.000 description 1
- 229940097277 hygromycin b Drugs 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- VUSYGSNEEYEGGX-UHFFFAOYSA-N indol-1-amine Chemical compound C1=CC=C2N(N)C=CC2=C1 VUSYGSNEEYEGGX-UHFFFAOYSA-N 0.000 description 1
- 125000000814 indol-3-yl group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C([*])C2=C1[H] 0.000 description 1
- 125000004531 indol-5-yl group Chemical group [H]N1C([H])=C([H])C2=C([H])C(*)=C([H])C([H])=C12 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 239000007972 injectable composition Substances 0.000 description 1
- 229940102223 injectable solution Drugs 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000007913 intrathecal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- QHDRKFYEGYYIIK-UHFFFAOYSA-N isovaleronitrile Chemical compound CC(C)CC#N QHDRKFYEGYYIIK-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000010907 mechanical stirring Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- ZTBCOZQPDZZCJO-UHFFFAOYSA-N methyl 2-(3-bromophenyl)-2-methylpropanoate Chemical compound COC(=O)C(C)(C)C1=CC=CC(Br)=C1 ZTBCOZQPDZZCJO-UHFFFAOYSA-N 0.000 description 1
- ULSSGHADTSRELG-UHFFFAOYSA-N methyl 2-(3-bromophenyl)acetate Chemical compound COC(=O)CC1=CC=CC(Br)=C1 ULSSGHADTSRELG-UHFFFAOYSA-N 0.000 description 1
- LPNOCGUZGTUSOJ-UHFFFAOYSA-N methyl 3-methylindazole-1-carboxylate Chemical compound C1=CC=C2N(C(=O)OC)N=C(C)C2=C1 LPNOCGUZGTUSOJ-UHFFFAOYSA-N 0.000 description 1
- NYGYORXJYHUSOR-UHFFFAOYSA-N methyl 4-[(2,5-dioxopyrrolidin-1-yl)oxycarbonylamino]indazole-1-carboxylate Chemical compound C1=CC=C2N(C(=O)OC)N=CC2=C1NC(=O)ON1C(=O)CCC1=O NYGYORXJYHUSOR-UHFFFAOYSA-N 0.000 description 1
- IKMAFQOFXZVFFB-UHFFFAOYSA-N methyl 4-[(4,5-dimethoxy-2,3-dihydro-1h-inden-1-yl)carbamoylamino]indazole-1-carboxylate Chemical compound C1CC(C(=C(OC)C=C2)OC)=C2C1NC(=O)NC1=C2C=NN(C(=O)OC)C2=CC=C1 IKMAFQOFXZVFFB-UHFFFAOYSA-N 0.000 description 1
- OIFGSAWJSYXFHR-UHFFFAOYSA-N methyl 4-[(5,6-dimethoxy-2,3-dihydro-1h-inden-1-yl)carbamoylamino]indazole-1-carboxylate Chemical compound C1CC2=CC(OC)=C(OC)C=C2C1NC(=O)NC1=C2C=NN(C(=O)OC)C2=CC=C1 OIFGSAWJSYXFHR-UHFFFAOYSA-N 0.000 description 1
- UYTPTIUWKWGGFJ-UHFFFAOYSA-N methyl 4-[(5-tert-butyl-2,2-difluoro-1,3-dihydroinden-1-yl)carbamoylamino]indazole-1-carboxylate Chemical compound C12=CC=C(C(C)(C)C)C=C2CC(F)(F)C1NC(=O)NC1=C2C=NN(C(=O)OC)C2=CC=C1 UYTPTIUWKWGGFJ-UHFFFAOYSA-N 0.000 description 1
- KGKOJERJAHOSLJ-UHFFFAOYSA-N methyl 4-[(5-tert-butyl-2-fluoro-2,3-dihydro-1h-inden-1-yl)carbamoylamino]indazole-1-carboxylate Chemical compound FC1CC2=CC(C(C)(C)C)=CC=C2C1NC(=O)NC1=C2C=NN(C(=O)OC)C2=CC=C1 KGKOJERJAHOSLJ-UHFFFAOYSA-N 0.000 description 1
- KHWPKGRJMSOBRI-UHFFFAOYSA-N methyl 4-[(6-fluoro-5-piperidin-1-yl-2,3-dihydro-1h-inden-1-yl)carbamoylamino]indazole-1-carboxylate Chemical compound C1=CC=C2N(C(=O)OC)N=CC2=C1NC(=O)NC(C1=CC=2F)CCC1=CC=2N1CCCCC1 KHWPKGRJMSOBRI-UHFFFAOYSA-N 0.000 description 1
- BURCLHFBYSNWJF-UHFFFAOYSA-N methyl 4-[[4-(2,6-dimethylmorpholin-4-yl)-2,3-dihydro-1h-inden-1-yl]carbamoylamino]indazole-1-carboxylate Chemical compound C1=CC=C2N(C(=O)OC)N=CC2=C1NC(=O)NC1CCC2=C1C=CC=C2N1CC(C)OC(C)C1 BURCLHFBYSNWJF-UHFFFAOYSA-N 0.000 description 1
- JWWIHTSMTIHTGK-UHFFFAOYSA-N methyl 4-[[4-(2-methylpiperidin-1-yl)-2,3-dihydro-1h-inden-1-yl]carbamoylamino]indazole-1-carboxylate Chemical compound C1=CC=C2N(C(=O)OC)N=CC2=C1NC(=O)NC1CCC2=C1C=CC=C2N1CCCCC1C JWWIHTSMTIHTGK-UHFFFAOYSA-N 0.000 description 1
- IVYJPWRXQTXABB-UHFFFAOYSA-N methyl 4-[[4-(3,3-difluoropiperidin-1-yl)-2,3-dihydro-1h-inden-1-yl]carbamoylamino]indazole-1-carboxylate Chemical compound C1=CC=C2N(C(=O)OC)N=CC2=C1NC(=O)NC1CCC2=C1C=CC=C2N1CCCC(F)(F)C1 IVYJPWRXQTXABB-UHFFFAOYSA-N 0.000 description 1
- JNKHNFFHNSIESN-UHFFFAOYSA-N methyl 4-[[4-(3-fluoropiperidin-1-yl)-2,3-dihydro-1h-inden-1-yl]carbamoylamino]indazole-1-carboxylate Chemical compound C1=CC=C2N(C(=O)OC)N=CC2=C1NC(=O)NC1CCC2=C1C=CC=C2N1CCCC(F)C1 JNKHNFFHNSIESN-UHFFFAOYSA-N 0.000 description 1
- QISJFUZXGABDMI-UHFFFAOYSA-N methyl 4-[[4-(3-methylpiperidin-1-yl)-2,3-dihydro-1h-inden-1-yl]carbamoylamino]indazole-1-carboxylate Chemical compound C1=CC=C2N(C(=O)OC)N=CC2=C1NC(=O)NC1CCC2=C1C=CC=C2N1CCCC(C)C1 QISJFUZXGABDMI-UHFFFAOYSA-N 0.000 description 1
- ZQKDPUTZNPLTRC-UHFFFAOYSA-N methyl 4-[[4-(4,4-difluoropiperidin-1-yl)-2,3-dihydro-1h-inden-1-yl]carbamoylamino]indazole-1-carboxylate Chemical compound C1=CC=C2N(C(=O)OC)N=CC2=C1NC(=O)NC1CCC2=C1C=CC=C2N1CCC(F)(F)CC1 ZQKDPUTZNPLTRC-UHFFFAOYSA-N 0.000 description 1
- SLLDSDHFZJGDFP-UHFFFAOYSA-N methyl 4-[[4-(4-fluoropiperidin-1-yl)-2,3-dihydro-1h-inden-1-yl]carbamoylamino]indazole-1-carboxylate Chemical compound C1=CC=C2N(C(=O)OC)N=CC2=C1NC(=O)NC1CCC2=C1C=CC=C2N1CCC(F)CC1 SLLDSDHFZJGDFP-UHFFFAOYSA-N 0.000 description 1
- YYCDICITOPVCIX-UHFFFAOYSA-N methyl 4-[[4-(4-methylpiperidin-1-yl)-2,3-dihydro-1h-inden-1-yl]carbamoylamino]indazole-1-carboxylate Chemical compound C1=CC=C2N(C(=O)OC)N=CC2=C1NC(=O)NC1CCC2=C1C=CC=C2N1CCC(C)CC1 YYCDICITOPVCIX-UHFFFAOYSA-N 0.000 description 1
- SVYQNXVHHHMROM-UHFFFAOYSA-N methyl 4-[[4-(8-azabicyclo[3.2.1]octan-8-yl)-2,3-dihydro-1h-inden-1-yl]carbamoylamino]indazole-1-carboxylate Chemical compound C1CCC2CCC1N2C1=CC=CC2=C1CCC2NC(=O)NC1=C2C=NN(C(=O)OC)C2=CC=C1 SVYQNXVHHHMROM-UHFFFAOYSA-N 0.000 description 1
- LBFLPGKLLOUUDH-UHFFFAOYSA-N methyl 4-[[4-(trifluoromethoxy)-2,3-dihydroindol-1-yl]carbamoylamino]indazole-1-carboxylate Chemical compound FC(OC1=C2CCN(C2=CC=C1)NC(NC1=C2C=NN(C2=CC=C1)C(=O)OC)=O)(F)F LBFLPGKLLOUUDH-UHFFFAOYSA-N 0.000 description 1
- XUNOUBBDMRUCKC-UHFFFAOYSA-N methyl 4-[[4-(trifluoromethyl)-2,3-dihydro-1h-inden-1-yl]carbamoylamino]indazole-1-carboxylate Chemical compound C1CC(C(=CC=C2)C(F)(F)F)=C2C1NC(=O)NC1=C2C=NN(C(=O)OC)C2=CC=C1 XUNOUBBDMRUCKC-UHFFFAOYSA-N 0.000 description 1
- REIZEKOMNQWLFO-UHFFFAOYSA-N methyl 4-[[5-(1-methoxy-2-methylpropan-2-yl)-2,3-dihydro-1h-inden-1-yl]carbamoylamino]indazole-1-carboxylate Chemical compound C1CC2=CC(C(C)(C)COC)=CC=C2C1NC(=O)NC1=CC=CC2=C1C=NN2C(=O)OC REIZEKOMNQWLFO-UHFFFAOYSA-N 0.000 description 1
- NMPGZWMZBITHHN-UHFFFAOYSA-N methyl 4-[[5-(2-methylpiperidin-1-yl)-2,3-dihydro-1h-inden-1-yl]carbamoylamino]indazole-1-carboxylate Chemical compound C1=CC=C2N(C(=O)OC)N=CC2=C1NC(=O)NC(C1=CC=2)CCC1=CC=2N1CCCCC1C NMPGZWMZBITHHN-UHFFFAOYSA-N 0.000 description 1
- BSKBHPZXNHKEHT-UHFFFAOYSA-N methyl 4-[[5-(3-methylpiperidin-1-yl)-2,3-dihydro-1h-inden-1-yl]carbamoylamino]indazole-1-carboxylate Chemical compound C1=CC=C2N(C(=O)OC)N=CC2=C1NC(=O)NC(C1=CC=2)CCC1=CC=2N1CCCC(C)C1 BSKBHPZXNHKEHT-UHFFFAOYSA-N 0.000 description 1
- IKYJAQJGVFBAPK-UHFFFAOYSA-N methyl 4-[[5-(4-methylpiperidin-1-yl)-2,3-dihydro-1h-inden-1-yl]carbamoylamino]indazole-1-carboxylate Chemical compound C1=CC=C2N(C(=O)OC)N=CC2=C1NC(=O)NC(C1=CC=2)CCC1=CC=2N1CCC(C)CC1 IKYJAQJGVFBAPK-UHFFFAOYSA-N 0.000 description 1
- GMGBGLPUPLVXKK-UHFFFAOYSA-N methyl 4-[[5-(4-phenylpiperidin-1-yl)-2,3-dihydro-1h-inden-1-yl]carbamoylamino]indazole-1-carboxylate Chemical compound C1=CC=C2N(C(=O)OC)N=CC2=C1NC(=O)NC(C1=CC=2)CCC1=CC=2N(CC1)CCC1C1=CC=CC=C1 GMGBGLPUPLVXKK-UHFFFAOYSA-N 0.000 description 1
- CGXCJLKYILLYPZ-UHFFFAOYSA-N methyl 4-[[5-(trifluoromethyl)-2,3-dihydroindol-1-yl]carbamoylamino]indazole-1-carboxylate Chemical compound FC(C=1C=C2CCN(C2=CC1)NC(=O)NC1=C2C=NN(C2=CC=C1)C(=O)OC)(F)F CGXCJLKYILLYPZ-UHFFFAOYSA-N 0.000 description 1
- YFWYJIUSAJYGKB-UHFFFAOYSA-N methyl 4-[[5-[4-(trifluoromethyl)piperidin-1-yl]-2,3-dihydro-1h-inden-1-yl]carbamoylamino]indazole-1-carboxylate Chemical compound C1=CC=C2N(C(=O)OC)N=CC2=C1NC(=O)NC(C1=CC=2)CCC1=CC=2N1CCC(C(F)(F)F)CC1 YFWYJIUSAJYGKB-UHFFFAOYSA-N 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- WDQDMWFXNRKENG-UHFFFAOYSA-N n-methoxy-4-pyridin-2-yl-2,3-dihydroinden-1-imine Chemical compound CON=C1CCC2=C1C=CC=C2C1=CC=CC=N1 WDQDMWFXNRKENG-UHFFFAOYSA-N 0.000 description 1
- JHPJSNXBRTXYFZ-UHFFFAOYSA-N n-methoxy-4-pyridin-3-yl-2,3-dihydroinden-1-imine Chemical compound CON=C1CCC2=C1C=CC=C2C1=CC=CN=C1 JHPJSNXBRTXYFZ-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- XTEGVFVZDVNBPF-UHFFFAOYSA-L naphthalene-1,5-disulfonate(2-) Chemical compound C1=CC=C2C(S(=O)(=O)[O-])=CC=CC2=C1S([O-])(=O)=O XTEGVFVZDVNBPF-UHFFFAOYSA-L 0.000 description 1
- KVBGVZZKJNLNJU-UHFFFAOYSA-M naphthalene-2-sulfonate Chemical compound C1=CC=CC2=CC(S(=O)(=O)[O-])=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-M 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 230000003040 nociceptive effect Effects 0.000 description 1
- 210000000929 nociceptor Anatomy 0.000 description 1
- 108091008700 nociceptors Proteins 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002895 organic esters Chemical class 0.000 description 1
- 125000001979 organolithium group Chemical group 0.000 description 1
- SMYVCBKLIWHGHU-UHFFFAOYSA-N oxane;thiomorpholine Chemical compound C1CCOCC1.C1CSCCN1 SMYVCBKLIWHGHU-UHFFFAOYSA-N 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- ULSIYEODSMZIPX-UHFFFAOYSA-N phenylethanolamine Chemical compound NCC(O)C1=CC=CC=C1 ULSIYEODSMZIPX-UHFFFAOYSA-N 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- MRRCMZXGQQXTQQ-UHFFFAOYSA-N propan-2-yl 4-aminoindazole-1-carboxylate Chemical compound C1=CC=C2N(C(=O)OC(C)C)N=CC2=C1N MRRCMZXGQQXTQQ-UHFFFAOYSA-N 0.000 description 1
- BSZLBDYMDBHLID-UHFFFAOYSA-N propan-2-yl 4-nitroindazole-1-carboxylate Chemical compound C1=CC=C2N(C(=O)OC(C)C)N=CC2=C1[N+]([O-])=O BSZLBDYMDBHLID-UHFFFAOYSA-N 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- DSDNAKHZNJAGHN-UHFFFAOYSA-N resinferatoxin Natural products C1=C(O)C(OC)=CC(CC(=O)OCC=2CC3(O)C(=O)C(C)=CC3C34C(C)CC5(OC(O4)(CC=4C=CC=CC=4)OC5C3C=2)C(C)=C)=C1 DSDNAKHZNJAGHN-UHFFFAOYSA-N 0.000 description 1
- DSDNAKHZNJAGHN-MXTYGGKSSA-N resiniferatoxin Chemical compound C1=C(O)C(OC)=CC(CC(=O)OCC=2C[C@]3(O)C(=O)C(C)=C[C@H]3[C@@]34[C@H](C)C[C@@]5(O[C@@](O4)(CC=4C=CC=CC=4)O[C@@H]5[C@@H]3C=2)C(C)=C)=C1 DSDNAKHZNJAGHN-MXTYGGKSSA-N 0.000 description 1
- 229940073454 resiniferatoxin Drugs 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 210000001044 sensory neuron Anatomy 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- 229940054269 sodium pyruvate Drugs 0.000 description 1
- SYXYWTXQFUUWLP-UHFFFAOYSA-N sodium;butan-1-olate Chemical compound [Na+].CCCC[O-] SYXYWTXQFUUWLP-UHFFFAOYSA-N 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 210000003594 spinal ganglia Anatomy 0.000 description 1
- 238000013222 sprague-dawley male rat Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- CBXCPBUEXACCNR-UHFFFAOYSA-N tetraethylammonium Chemical compound CC[N+](CC)(CC)CC CBXCPBUEXACCNR-UHFFFAOYSA-N 0.000 description 1
- BSYVTEYKTMYBMK-UHFFFAOYSA-N tetrahydrofurfuryl alcohol Chemical compound OCC1CCCO1 BSYVTEYKTMYBMK-UHFFFAOYSA-N 0.000 description 1
- QEMXHQIAXOOASZ-UHFFFAOYSA-N tetramethylammonium Chemical compound C[N+](C)(C)C QEMXHQIAXOOASZ-UHFFFAOYSA-N 0.000 description 1
- 230000004797 therapeutic response Effects 0.000 description 1
- XDLNRRRJZOJTRW-UHFFFAOYSA-N thiohypochlorous acid Chemical compound ClS XDLNRRRJZOJTRW-UHFFFAOYSA-N 0.000 description 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 125000005034 trifluormethylthio group Chemical group FC(S*)(F)F 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- ZQJYTTPJYLKTTI-UHFFFAOYSA-M zinc;2h-pyridin-2-ide;bromide Chemical compound Br[Zn+].C1=CC=N[C-]=C1 ZQJYTTPJYLKTTI-UHFFFAOYSA-M 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Materials For Photolithography (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/459,925 US7015233B2 (en) | 2003-06-12 | 2003-06-12 | Fused compounds that inhibit vanilloid subtype 1 (VR1) receptor |
| US10/864,068 US7375126B2 (en) | 2003-06-12 | 2004-06-09 | Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW201300361A true TW201300361A (zh) | 2013-01-01 |
Family
ID=33555102
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW101107398A TW201300361A (zh) | 2003-06-12 | 2004-06-14 | 抑制香草類化物受體(vanilloid receptor)次型1(vr1)受體之稠合化合物 |
| TW093117059A TWI394569B (zh) | 2003-06-12 | 2004-06-14 | 抑制香草類化物受體(vanilloid receptor)次型1(vr1)受體之稠合化合物 |
| TW099119548A TWI366461B (en) | 2003-06-12 | 2004-06-14 | Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW093117059A TWI394569B (zh) | 2003-06-12 | 2004-06-14 | 抑制香草類化物受體(vanilloid receptor)次型1(vr1)受體之稠合化合物 |
| TW099119548A TWI366461B (en) | 2003-06-12 | 2004-06-14 | Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
Country Status (20)
| Country | Link |
|---|---|
| EP (2) | EP1658269B1 (enExample) |
| JP (2) | JP4857113B2 (enExample) |
| KR (2) | KR101138216B1 (enExample) |
| CN (1) | CN102617464A (enExample) |
| AT (2) | ATE510824T1 (enExample) |
| AU (2) | AU2004247721C1 (enExample) |
| BR (1) | BRPI0411116A (enExample) |
| CA (2) | CA2526872C (enExample) |
| CY (2) | CY1108713T1 (enExample) |
| DE (1) | DE602004017329D1 (enExample) |
| DK (2) | DK1658269T3 (enExample) |
| ES (1) | ES2318308T3 (enExample) |
| IL (4) | IL172457A (enExample) |
| MX (1) | MXPA05013550A (enExample) |
| NZ (3) | NZ590234A (enExample) |
| PL (2) | PL2017265T3 (enExample) |
| PT (2) | PT1658269E (enExample) |
| SI (2) | SI2017265T1 (enExample) |
| TW (3) | TW201300361A (enExample) |
| WO (1) | WO2004111009A1 (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004089296A2 (en) | 2003-04-03 | 2004-10-21 | The Regents Of The University Of California | Improved inhibitors for the soluble epoxide hydrolase |
| US20090018092A1 (en) | 2004-03-16 | 2009-01-15 | The Regents Of The University Of California | Reducing Nephropathy with Inhibitors of Soluble Epoxide Hydrolase and Epoxyeicosanoids |
| AU2005295167B2 (en) | 2004-10-20 | 2012-05-10 | The Regents Of The University Of California | Improved inhibitors for the soluble epoxide hydrolase |
| WO2006062982A2 (en) | 2004-12-07 | 2006-06-15 | Locus Pharmaceuticals, Inc. | Urea inhibitors of map kinases |
| JP2008523072A (ja) | 2004-12-07 | 2008-07-03 | ルーカス ファーマシューティカルズ, インコーポレイテッド | タンパク質キナーゼの阻害剤 |
| CA2624307C (en) | 2005-10-07 | 2014-04-29 | Glenmark Pharmaceuticals S.A. | Substituted benzofused derivatives and their use as vanilloid receptor ligands |
| CA2626579A1 (en) * | 2005-10-25 | 2007-05-03 | Abbott Laboratories | Formulation comprising a drug of low water solubility and method of use thereof |
| AU2006306146A1 (en) | 2005-10-28 | 2007-05-03 | Abbott Laboratories | Indazole derivatives that inhibit TRPV1 receptor |
| TW200808723A (en) | 2006-03-13 | 2008-02-16 | Univ California | Conformationally restricted urea inhibitors of soluble epoxide hydrolase |
| RU2450006C2 (ru) * | 2006-04-18 | 2012-05-10 | Эбботт Лэборетриз | Антагонисты ванилоидного рецептора подтипа 1(vr1) и их применение |
| WO2009081222A1 (en) | 2007-12-21 | 2009-07-02 | Glenmark Pharmaceuticals, S.A. | Substituted tricyclic pyridine or pyrimidine vanilloid receptor ligands |
| CN101925575B (zh) | 2008-01-28 | 2014-06-18 | 株式会社爱茉莉太平洋 | 作为香草酸受体拮抗剂的化合物、其异构体或其药物学可接受的盐、及包含这些化合物的药物组合物 |
| CN102137851B (zh) | 2008-07-02 | 2014-08-27 | 株式会社爱茉莉太平洋 | 作为香草素受体拮抗剂的化合物、其异构体或其药学可接受的盐以及包含它们的药物组合物 |
| AR073631A1 (es) * | 2008-10-17 | 2010-11-17 | Abbott Lab | Antagonistas del receptor transitorio potencial de vanilloides 1 ( trpv1) utiles para tratar inflamacion y dolor |
| US9296693B2 (en) | 2010-01-29 | 2016-03-29 | The Regents Of The University Of California | Acyl piperidine inhibitors of soluble epoxide hydrolase |
| HRP20161786T1 (hr) | 2011-05-13 | 2017-03-10 | Array Biopharma, Inc. | Pirolidinil urea, pirolidinil tiourea i pirolidinil gvanidin spojevi kao inhibitori trka kinaze |
| CN104364236B (zh) * | 2012-05-09 | 2018-01-16 | 拜尔农作物科学股份公司 | 5‑卤代吡唑二氢茚基甲酰胺 |
| WO2014078372A1 (en) | 2012-11-13 | 2014-05-22 | Array Biopharma Inc. | Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors |
| UA117573C2 (uk) | 2012-11-13 | 2018-08-27 | Ерей Біофарма Інк. | Біциклічні сполуки сечовини, тіосечовини, гуанідину й ціаногуанідину, придатні для лікування болю |
| WO2014078328A1 (en) | 2012-11-13 | 2014-05-22 | Array Biopharma Inc. | N-bicyclic aryl,n'-pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors |
| WO2014078331A1 (en) | 2012-11-13 | 2014-05-22 | Array Biopharma Inc. | N-(arylalkyl)-n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors |
| US9809578B2 (en) | 2012-11-13 | 2017-11-07 | Array Biopharma Inc. | Pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trkA kinase inhibitors |
| US9981959B2 (en) | 2012-11-13 | 2018-05-29 | Array Biopharma Inc. | Thiazolyl and oxazolyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors |
| US9828360B2 (en) | 2012-11-13 | 2017-11-28 | Array Biopharma Inc. | Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors |
| WO2014078325A1 (en) | 2012-11-13 | 2014-05-22 | Array Biopharma Inc. | N-(monocyclic aryl),n'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as trka kinase inhibitors |
| UA116455C2 (uk) | 2012-11-13 | 2018-03-26 | Еррей Біофарма Інк. | Сполуки n-піролідинілсечовини, n'-піразолілсечовини, тіосечовини, гуанідину та ціаногуанідину як інгібітори кінази trka |
| US9822118B2 (en) | 2012-11-13 | 2017-11-21 | Array Biopharma Inc. | Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors |
| CN109970614B (zh) | 2014-05-15 | 2023-01-13 | 阵列生物制药公司 | 作为trka激酶抑制剂的化合物及其用途 |
| WO2017190107A1 (en) * | 2016-04-29 | 2017-11-02 | Board Of Regents, The University Of Texas System | Sigma receptor binders |
| DE102022104759A1 (de) | 2022-02-28 | 2023-08-31 | SCi Kontor GmbH | Co-Kristall-Screening Verfahren, insbesondere zur Herstellung von Co-Kristallen |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW536734B (en) * | 2000-07-31 | 2003-06-11 | Clariant Int Ltd | Process for manufacturing a microelectronic device |
| WO2003014064A1 (en) * | 2001-07-31 | 2003-02-20 | Bayer Healthcare Ag | Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists |
| JP2003192587A (ja) * | 2001-12-26 | 2003-07-09 | Bayer Ag | 尿素誘導体 |
| WO2003070247A1 (en) * | 2002-02-20 | 2003-08-28 | Abbott Laboratories | Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| GB0206876D0 (en) * | 2002-03-22 | 2002-05-01 | Merck Sharp & Dohme | Therapeutic agents |
| WO2003097586A1 (en) * | 2002-05-17 | 2003-11-27 | Janssen Pharmaceutica N.V. | Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
-
2004
- 2004-06-10 BR BRPI0411116-8A patent/BRPI0411116A/pt not_active IP Right Cessation
- 2004-06-10 AU AU2004247721A patent/AU2004247721C1/en not_active Ceased
- 2004-06-10 DE DE602004017329T patent/DE602004017329D1/de not_active Expired - Lifetime
- 2004-06-10 PT PT04754996T patent/PT1658269E/pt unknown
- 2004-06-10 DK DK04754996T patent/DK1658269T3/da active
- 2004-06-10 DK DK08166079.7T patent/DK2017265T3/da active
- 2004-06-10 SI SI200431715T patent/SI2017265T1/sl unknown
- 2004-06-10 EP EP04754996A patent/EP1658269B1/en not_active Expired - Lifetime
- 2004-06-10 CN CN2012100573625A patent/CN102617464A/zh active Pending
- 2004-06-10 KR KR1020057023829A patent/KR101138216B1/ko not_active Expired - Fee Related
- 2004-06-10 AT AT08166079T patent/ATE510824T1/de active
- 2004-06-10 PL PL08166079T patent/PL2017265T3/pl unknown
- 2004-06-10 PL PL04754996T patent/PL1658269T3/pl unknown
- 2004-06-10 NZ NZ590234A patent/NZ590234A/en not_active IP Right Cessation
- 2004-06-10 SI SI200430995T patent/SI1658269T1/sl unknown
- 2004-06-10 NZ NZ543713A patent/NZ543713A/en not_active IP Right Cessation
- 2004-06-10 JP JP2006533722A patent/JP4857113B2/ja not_active Expired - Fee Related
- 2004-06-10 NZ NZ578264A patent/NZ578264A/en not_active IP Right Cessation
- 2004-06-10 CA CA2526872A patent/CA2526872C/en not_active Expired - Fee Related
- 2004-06-10 CA CA2756058A patent/CA2756058A1/en not_active Abandoned
- 2004-06-10 EP EP08166079A patent/EP2017265B1/en not_active Expired - Lifetime
- 2004-06-10 ES ES04754996T patent/ES2318308T3/es not_active Expired - Lifetime
- 2004-06-10 PT PT08166079T patent/PT2017265E/pt unknown
- 2004-06-10 WO PCT/US2004/018590 patent/WO2004111009A1/en not_active Ceased
- 2004-06-10 AT AT04754996T patent/ATE411982T1/de active
- 2004-06-10 KR KR1020117017610A patent/KR101150324B1/ko not_active Expired - Fee Related
- 2004-06-10 MX MXPA05013550A patent/MXPA05013550A/es active IP Right Grant
- 2004-06-14 TW TW101107398A patent/TW201300361A/zh unknown
- 2004-06-14 TW TW093117059A patent/TWI394569B/zh not_active IP Right Cessation
- 2004-06-14 TW TW099119548A patent/TWI366461B/zh not_active IP Right Cessation
-
2005
- 2005-12-08 IL IL172457A patent/IL172457A/en not_active IP Right Cessation
-
2009
- 2009-01-14 CY CY20091100044T patent/CY1108713T1/el unknown
-
2010
- 2010-08-01 IL IL207335A patent/IL207335A/en not_active IP Right Cessation
- 2010-12-17 AU AU2010257277A patent/AU2010257277B2/en not_active Ceased
-
2011
- 2011-03-07 JP JP2011049274A patent/JP2011153148A/ja active Pending
- 2011-07-28 CY CY20111100738T patent/CY1111945T1/el unknown
- 2011-10-27 IL IL215997A patent/IL215997A0/en unknown
- 2011-10-30 IL IL216046A patent/IL216046A0/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI394569B (zh) | 抑制香草類化物受體(vanilloid receptor)次型1(vr1)受體之稠合化合物 | |
| US8487116B2 (en) | Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor | |
| US6436923B1 (en) | Compounds and methods for modulation of estrogen receptors | |
| TW200808808A (en) | Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof | |
| US7375126B2 (en) | Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor | |
| JPH0443917B2 (enExample) | ||
| JP2007537229A (ja) | ジアルキルオキシインドールの新規なピペラジン誘導体 | |
| AU2011244937A1 (en) | Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor | |
| HK1129383A (en) | Fused compounds that inhibit vanilloid receptor subtype1(vr1) receptor | |
| HK1093727B (en) | Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor | |
| HK1126488B (en) | Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |